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Swollen cells expel osmolytes to decrease volume in a process referred to as 
Regulatory Volume Decrease, or RVD. The plasma membrane current ICl,swell is 
ubiquitously expressed in mammalian cells and contributes significantly to RVD. In a 
variety of cell types, activation of ICl,swell is enhanced by nucleotide signaling. In this 
study, we used human astrocytoma cells to examine whether nucleotide signaling is 
necessary or sufficient for ICl,swell activation. Three clones of the 1321N1 human 
astrocytoma cell line were used for voltage clamp recordings. One clone was transfected 
with P2Y1 receptors, another with P2Y2 receptors and a third was devoid of any P2Y 
receptors (Parental). In physiological solutions, hyposmotic exposure (HOE) caused 
increased membrane conductance in each cell line.  HOE also depolarized the reversal 
potential in P2Y1 and P2Y2, but not in Parental, cell lines. In solutions containing no 
permeable cations, HOE activated ICl,swell in morphologically round cells of each cell line 
and in morphologically flat P2Y1 and P2Y2 cells. However, morphologically flat 
Parental cells did not demonstrate HOE-induced ICl,swell activity. Exogenous ATP 
activated a chloride current with an electrophysiological profile different from ICl,swell. I 
conclude that P2Y nucleotide signaling may play a role in gating ICl,swell, but is not 
necessary for its activation. P2Y receptor stimulation is sufficient to activate a chloride 
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I. Background and Literature Review 
 
A. Glial Cells 
Introduction 
 
 Glial cells were discovered during the mid-19
th
 century. This was not too long 
after Scwhann and Schleiden theorized that all living matter was composed of cells in 
1839 (Kimelberg 2004). It was Rudolf Virchow who first coined the term neuroglia, 
meaning “neural-cement,” in 1856 (Ndubaku & de Bellard 2008). Virchow’s 
histochemical stains illustrated clear distinctions between neurons and glia but were 
unable to delineate between the different subtypes of glia. Using the black chrome-silver 
reaction Camillo Golgi was the first to distinguish radial glia from other glia and neurons 
in 1895 (Kimelberg 2004). Ramon y Cajal was the first to use the term astrocyte to 
describe the fibrous and protoplasmic glial subset (Somjen 1988). He identified 
astrocytes using gold sublimate, which stained for what is known today as glial fibrillary 
acidic protein, GFAP. In 1920 Cajal’s student del Rio Hortega was able to distinguish 
oligodendrondrocytes and microglia from the other two glial subsets (Somjen 1988).  
 Neuroglia have since been split into two broader classes of macroglia and 
microglia, the latter being the primary immune cell in the brain. Macroglia in the 
peripheral nervous system (PNS) consist of Schwann cells and satellite cells. Schwann 
cells’ main role is that of axon myelination (Ndubaka & de Bellard 2008). Their long end 
feet wrap around myelinated fibers of the PNS resulting in faster signal transduction. 
Satellite cells line the exterior portion of the PNS and regulate the exterior chemical 
environment (Topilko 2007). Macroglia in the CNS consist of four distinct types; 
oligodendrocytes, radial glia, ependymal cells and astrocytes. Similar to Schwann cells, 
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oligodendrocytes have small somas and large end feet that are responsible for axon 
myelination (Ndubaka & de Bellard 2008). Radial glia have many roles in the CNS. In 
the developing brain, radial glia act as scaffolding for immature neuron migration 
(Kimelberg 2004). In the cerebellum and retina, radial glia are involved in synaptic 
plasticity and bidirectional communication with neurons, respectively. Ependymal cells 
create the walls of the ventricles (Meiniel 2007). Astrocytes are the most numerous cells 




 Astrocytes account for approximately 20-30% of brain cells in the mature CNS 
and are crucial for maintaining relative homeostasis (Kimelberg 2004, Hertz & Zielke 
2004). In the microenvironment astrocytes mediate neurotransmitter and ionic 
homeostasis, synaptic formation, neuronal excitability and migration, detoxification and 
maintenance of the blood brain barrier (Markiewicz & Lukomska 2006). Proper astrocyte 
function is very important for the function of the brain as a whole. Astrocytes are known 
to secrete a wide variety of neurotrophic factors, such as nerve growth factor, NGF, and 
brain-derived neurotrophic factor BDNF (Villegas, Poletta & Carri 2003). Astrocytes 
regulate the extracellular space near synapses after high neuronal output by absorbing 
potassium (Leis, Bekar & Walz 2005, Olsen, Campbell & Sontheimer 2007) as well as 
neurotransmitters (Hertz & Zielke 2004). 
 The electrophysiology of astrocytes is quite uniform. Sontheimer and colleagues 
recorded electrically from astrocytes in three different regions of the rat brain; the 
hippocampus, cerebral cortex and spinal cord. Each cell type had very similar 
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electrophysiological properties (Bordey & Sontheimer 2000). All cells expressed 
transient KA currents, rectifying KDR currents and inward Na
+
 currents in all three regions 
at all stages of development. Older animals also exhibited KIR in all three regions. 
Sontheimer and colleagues also recorded from Bergmann glia in the cerebellum that 
appeared not to have KDR or KA currents. After employing leak subtraction, both KDR and 
KA currents were also found in these cells. 
 Originally astrocytes, as well as other glial cells, were thought to simply provide 
neurons with structural support, but in more recent decades it has become clear that 
astrocytes also are directly involved in synaptic communication. They are able to 
stabilize as well as modulate synaptic activity (Haydon 2000). Astrocytes express many 
neurotransmitter receptors that, when activated, initiate calcium signaling (Schipke & 
Kettenman 2002, Villegas et al. 2003). These calcium waves spread between adjacent 
astrocytes via gap junctions and nucleotide signaling (Inoue, Schuichi & Tsuda 2007), 
which can then trigger release of ATP and glutamate; the main mediators of neuron-glia 
cross-talk (Villegas et al. 2003). Astrocytes also have been found to communicate with 




 Astrocytes participate, along with microglia, in the general immune response of 
the brain by secreting pro-inflammatory cytokines Tumor Growth Factor-1, Tumor 
Necrosis Factor-, and Interleukins 1 and 6 (Dong 2001). While a controlled 
inflammatory response can be beneficial under many circumstances, it has been observed 
that in pathological states these pro-inflammatory mediators can lead to neuronal damage 
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and cell death. The neurotoxic effects of TNF- (Kielen & Drew 205) and IL-1 (John, 
Lee & Brosnan 2003) have both been illustrated in vitro. The damage caused by 
inflammation is thought to contribute to several disease states such as Alzheimer’s 
disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS) 
and multiple sclerosis (MS) (Markiewicz & Lukomska 2006). 
 Rapid swelling of astrocytes is observed after numerous traumatic brain injuries, 
including stroke (Barron et al. 1988, Kimelberg et al. 2000, Mongin & Kimelberg 2005, 
Somjen 2004). Decreased extracellular space (ECS) is also observed after the traumatic 
event (Van Harreveld 1972). While other factors, such as dendritic swelling, could 
contribute to the decrease in ECS, it would seem that the swelling of astrocytes must play 
a significant role (Mongin & Kimelberg 2005). After 30 minutes of a focal ischemia 
astrocytes’ intermediate metabolism is compromised leading to a decreased buffering 
capacity for extracellular potassium and glutamate (Hagberg et al. 2001). The 
combination of decreased ECS and astrocyte buffering capacity causes an increase of 
harmful substances in the ECS, including excitatory amino acids (EAA), reactive oxygen 
species (ROS), prostanoids and nitric oxide (NO) (Sykova & Chvatal 2000). It is not 
surprising to find that edema is a common cause of delayed death after stroke and other 
brain injury (Markiewicz & Lukomska 2006). The mechanisms of cell swelling and 
recovery in the brain are not fully understood. Future research will address some of these 









 Adenosine tri-phosphate, ATP, a purine nucleotide, plays important roles in many 
different areas of the life sciences. Most notably ATP is the “molecular currency” of 
energy transfer within a cell. Much of the study of biochemistry is concerned with its 
synthesis and metabolism. ATP is generated during glycolysis, photosynthesis and 
cellular respiration and the energy stored in the three phosphate bonds can be used for 
many cellular functions. Transmembrane pumps, such as the Na-K-ATPase, use the 
energy stored in the phosphate bonds of ATP to move molecules against their 
electrochemical gradient. ATP is also important biologically in aspects other than as a 
transducer of chemical potential energy. Cellular signaling pathways utilize ATP. In 
intracellular signal transduction pathways, ATP is used as a substrate by kinases that 
phosphorylate proteins and lipids, and adenylate cyclase that produces the second 
messenger molecule, cyclic AMP. More recently ATP has been found to be involved in 
intercellular signaling, acting in autocrine, paracrine and neurocrine mechanisms on 
extracellular nucleotide receptors (Burnstock 1972).  
 Perhaps due to the fact that ATP is such an important molecule for cell 
metabolism it was difficult for the scientific community to accept that it was involved in 
intercellular signaling. The first observation that ATP can act extracellularly occurred 
during experiments on cardiac tissue in 1929 (Drury & Szent-Györgyi 1929). Later it was 
found to act in the intestine (Gillespie 1934) and parts of the spinal cord (Buchthal, 
Engbaek, Sten-Knudsen & Thomasen 1947), as well as other areas. Exogenous ATP 
causes electrophysiological changes in certain brain regions (Galindo 1967) and acts as 
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an antagonist to certain anesthetics (Kuperman, Okamoto, Beyer & Volpert 1964). In 
1970 Geoffrey Burnstock postulated that ATP is used for specific intercellular signaling 
(Burnstock 1970). He discovered nerves in the autonomic nervous system innervating the 
gut and bladder that utilized ATP as their neurotransmitter. Since then ATP has been 
described as a neurotransmitter in the autonomic, central and nociceptive nervous 




  Early studies of ATP release usually involved bioluminescent measurements of 
the bathing solution of the cells subjected to mechanical stress (Schwiebert & Zsembery 
2003). This technique resulted in calculated concentrations of ATP in the nanomolar 
range, well below the micromolar concentrations needed to stimulate most nucleotide 
receptors (Bours, Swennen, Virgilio, Cronstein & Danelie 2006). Using a different 
technique, Dubyak and colleagues discovered that ATP concentrations in the area near 
the cell membrane, termed the pericellular space, are several orders of magnitude higher 
than that of the bulk bath solution (Joseph, Buchakjian & Dubyak 2003). The technique 
used membrane attached protein-A luciferase to analyze ATP release in the pericellular 
space. Micromolar amounts of ATP were found to accumulate in the pericellular space of 
human astrocytoma cells (Joseph et al. 2003) and primary airway epithelial cells (Okada, 
Nicholas, Kreda, Lazarowski & Boucher 2006) when stimulated by Ca
2+
 mobilizing 




ATP Release during Cell Swelling 
 
 It has been shown in many cell types that ATP is released during cellular swelling 
(Sabirov, Dutta & Okada 2001, Wehner, Olsen, Tinel, Kinne-Saffran & Kinne 2003). 
When using a technique that measures ATP concentration in close proximity to the cell 
membrane, ATP concentrations increase to 10s of µM when cells are exposed to 
hyposmotic media (Dubyak & El-Moatassum 1993).  This concentration of ATP is large 
enough to stimulate the P2Y sub-type of nucleotide receptors (Dezaki, Tsumura, Maeno, 
Okada 2000). The effects of ATP release on RVD were studied by exposing human 
intestine 407 cells to hyposmotic media and measuring cell volume over a time course of 
several minutes (Dezaki 2000). In control experiments the cells exhibited RVD. In 
separate experiments, cells were exposed to either suramin, a broad P2 receptor blocker, 
apyrase, an ATP-hydrolyzing enzyme, ATP or UTP, along with the hyposmotic media. 
Both suramin and apyrase blunted the RVD effect while the addition of micromolar 
amounts of ATP and UTP caused an increase in the amount of RVD. This suggests that 
the release of ATP during cell swelling plays a significant role in the mechanism of RVD. 
Similar effects of suramin and apyrase on RVD responses have been found in other cell 
types (Wang, Roman, Lidofsky & Fritz 1996, Roman et al. 1997, Roman, Feranchak, 
Salter, Wang & Fritz 1999). 
 The mechanism for ATP release during cell swelling has been a highly debated 
subject for more than a decade. Early proposed mechanisms for ATP release included the 
cystic fibrosis transmembrane conductance regulator, CFTR, (Schwiebert et al. 1995) and 
the volume-regulated anion channel, VRAC (Hisadome et al. 2002). Evidence against 
both CFTR and VRAC as ATP conductive pathways has been demonstrated in human 
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intestine 407 cells (Hazama et al. 1999) as well as mouse mammary C127 cells (Hazama 
et al. 2000). Although these two specific anion channels are unlikely to mediate ATP 
release, other evidence suggests an anion channel is likely. In recent studies (Sabirov et 
al. 2001, Dutta, Okada & Sabirov 2002) a maxi-conductance, volume-activated anion 
channel has been found to facilitate swelling induced ATP release. A similar maxi-anion 
channel in kidney macula densa cells conducts ATP during exposure to increased 
extracellular NaCl levels (Bell et al. 2003). Another proposed mechanism of release is 
through connexin 43 hemichannels. C6 glioma cells transfected with connexin 43 
demonstrated ATP release and calcium signaling upon mechanical stimulation, while the 
parental cells lacking connexin 43 were unable to do so (Stout, Costantin, Naus & Charls 
2002, Kang et al. 2008). 
 The main effect of autocrine ATP signaling appears to involve calcium signaling. 
In human intestine 407 cells, activation of P2Y receptors by micromolar amounts of ATP 
and UTP increases intracellular Ca
2+
 (Dezaki et al. 2000). Hyposmotic exposure also 
increases intracellular Ca
2+
 and exogenous ATP or UTP augments this response. In these 
cells the increase in intracellular Ca
2+
 is due to release from intracellular stores as well as 
from influx via Ca
2+
-permeable cation channels (Dezaki et al. 2000, Hafting, Haug, 
Ellefsen & Sand 2006). These increases in intracellular Ca
2+
 activate the intermediate-
conductance K
+
 and IK channels in Intestine 407 cells (Wang, Morishima & Okada 2003) 
and large-conductance K
+
, BK, channels in Vero cells (Hafting et al. 2006). Although 
increased extracelluar ATP was not able to activate chloride currents in Intestine 407 
cells (Dezaki et al. 2000), more recent research in rat primary cultured astrocytes 
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indicates that perhaps ATP can activate VRACs via P2Y2 signaling (Darby, Kuzmiski, 




 Another factor in the nucleotide signaling cascade is the presence of nucleotide 
converting enzymes in the extracellular space. When ATP is accumulated in the 
pericellular space it comes into contact with many nucleotide-converting ecto-enzymes 
that convert ATP to ADP, AMP, adenosine, inosine and hypoxanthine. Converting ecto-
enzyme families include ecto-nucleoside triphosphate diphosphohydrolase (E-NTDPase) 
(Zimmermann 1996), which dephosphorylates ATP and ADP, ecto-nucleotide 
pyrophosphatase/phosphodiesterase (E-NPP) (Stefan 2005), which can hydrolyze 
pyrophosphate and phosphodiester bonds in many molecules including nucleotides, and 
ecto-5’-nucleotidase (Zimmermann 1992), which dephosphorylates AMP to adenosine. 
Adenosine can then be further broken down by adenosine deaminase (ADA) and purine 
nucleoside phophorylase (PNP) or be transported, by active or facilitated diffusion, back 
into the cell (Thorn & Jarvis 1996). Most cell types express one or more of these 
enzymes on the extracellular side of their membrane. Thus ATP and other nucleotide 
concentrations are determined not only by the amount released but also by the metabolic 
rate of these ecto-enzymes (for review see Yegutkin 2008).  
 
Nucleotide Receptor Subtypes 
 
 The membrane receptors whose ligands are purines and pyrimidines are 
commonly referred to as nucleotide receptors.  There are at least three different families 
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of nucleotide receptors; P1 (also referred to as adenosine receptors), P2X and P2Y 
receptors. Nucleotide receptors have been found to be located in many regions of the 
body and function in an equally wide array of cellular processes.  
 P1 receptors are G-protein coupled receptors. There are four P1 receptor subtypes; 
A1, A2A, A2B and A3, which all respond to adenosine as their endogenous agonist. 
When A1 and A3 receptors are activated they stimulate Gs, which causes an increase in 
cAMP.  Activation of A2A and A2B receptors stimulates Gi, which causes a decrease in 
cAMP (Burnstock 2007). P1 receptor activation causes decreased heart rate, coronary 
vasodilatation and A2B, in combination with neutrin-1, is involved with axon elongation 
in neurons (see Fredholm, Ijzerman, Jacobson & Klotz 2001 for review of P1 receptors).  
 P2X receptors are ionotropic with two transmembrane domains. There are seven 
cloned P2X subtypes; P2X1-7, which all respond to ATP as their endogenous agonist. 
P2X receptors act as cation channels and upon activation by ATP, allow the flow of 
sodium, potassium and in some cases calcium. This causes depolarization of the cell 
membrane, which in turn activates Ca
2+ 
channels (Dubyak & El-Moatassum 1993). 
P2X1-6 are all very similar in structure while P2X7 has an elongated intracellular peptide 
sequence on the carboxy end. When exposed to ATP it initially functions as the other 
P2X receptors, however if the ATP exposure is prolonged its pore enlarges and larger 
molecules can flow through. It is mainly expressed in immune cells and glia, and seems 
to allow the release of proinflamatory cytokines (Burnstock 2008). P2X receptors have 
been located in neurons, glia, bone, muscle, endothelium and hematopoietic cells 
(Burnstock 2004, North 2002), and have functions including fast synaptic transmission 
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(Bardoni 1997), neurotransmitter release (Khakh & Henderson 1998) and pain signaling 
(Cockayne et al. 2000).  
 P2Y receptors are G-coupled with seven transmembrane spanning domains. There 
are eight P2Y receptor subtypes that have been cloned; P2Y1, P2Y2, P2Y4, P2Y6 and 
P2Y11 through P2Y14 (Burnstock 2007, Erb, Weaver, Seye & Weisman 2006). P2Y 
receptors respond to a more varied array of endogenous agonists, including ATP, ADP 
and even UTP. The strength of response to these agonists varies by receptor subtype, 
which is sometimes used to identify receptor subtype. For instance, if a cell exhibits a 
physiological response to ATP and UTP, but not ADP then the responsible receptor is 
either P2Y2 or P2Y4. G-proteins utilized by P2Y receptors are Gi, Go, Gs, Gq/G11, Gi, 
G12 and Gi/Go (Erb et al. 2006). Some P2Y receptor subtypes have specific G-proteins 
they associate with, but many can associate with multiple. The P2Y2 receptor can 
activate Go, Gq/G11 and G12 (Erb et al. 2006). Stimulation of these G-proteins by 
recombinant P2Y receptors can either activate phospholipase C (PLC) or adenylate 
cyclase, causing intracellular Ca
2+
 release or changes in cAMP levels, respectively 
(Burnstock 2007). P2Y signaling is responsible for numerous physiological responses 
(Burnstock 2007). P2Y receptors are thought to play a role in the activation of ion 
channels, including the volume-regulated anion channel (Darby et al. 2003) and of N-
type Ca
2+
 channels (Abbracchio et al. 2006). P2Y receptor expression has been shown to 
influence cell proliferation in a number of cell types (Bagchi et al. 2005) and is 
upregulated in response to tissue injury (Ahn, Camden, Schrader, Redman & Turner 
2000, Schafer, Sedehizade, Welte & Reiser 2003, Tu et al. 2000). In the brain, nucleotide 
signaling seems to be neuroprotective. The P2Y2 receptor subtype expression has been 
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found to increase cell survival rates in cultured astrocytes subjected to trauma (Chorna et 
al. 2004).  
 Although specific agonists exist for many of the nucleotide receptor subtypes, the 
use of pharmacology to identify subtype activation is difficult. There is much overlap in 
the agonist profiles of many nucleotide receptors, and often specificity is very 
concentration dependent (Burnstock 2007). Similarly, agonists for nucleotide receptors 
lack specificity. In this study genetically modified cells are used to overcome this 
obstacle. Cells transfected with particular P2Y receptors are utilized to ensure 
physiological responses can be attributed to specific receptor subtypes.  
 
C. Cell Swelling and Regulatory Volume Decrease 
Cellular Swelling 
 
The concept of cell volume regulation is so fundamental that many first learn of it 
in high school biology. Cells collected from a student’s mouth, or perhaps a nearby pond, 
are studied under a microscope while tap water replaces the normal liquid environment. 
The cells viewed in the microscope increase in size and eventually burst.  However, cells 
exposed to a solution of one-half tap water and one-half liquid from natural environment 
will initially swell, but eventually shrink back to their original size. This second outcome 
is reproducible in almost all animal cells (for one exception see De Smet, Oike, 
Droogmans, Van Driessche, & Nilius 1994).  
Cells also are subject to changes in volume due to a number of physiological 
situations. Renal cells must respond to osmotic changes that occur during antidiuresis and 
diuresis (Beck 1988). Pathological situations in the brain, such as ischemia and traumatic 
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brain injury (TBI) often present with cellular swelling (Barron et al. 1988, Kimelberg et 
al. 2000, Somjen 2002). Causes for swelling can even be cell specific. For instance, 
astrocytes swell when exposed to millimolar levels of glutamate (Bender, Schousboe, 
Reichelt & Norneberg 1998, Koyama, Baba & Iwata 1991). Transepithelial transport of 
solutes into cells can cause cell swelling even when the extracellular environment 




 Most biological matter is water, which flows easily through the plasma membrane 
of almost all mammalian cells. Thus, a cell swells because it has taken on more water. 
Likewise, when a cell loses water it shrinks. The relation of water flux through a semi-
permeable membrane can be described by the equation: 
  
Jv = Lp (∆p – ∆π)  
 
where Jv is the flux of water, Lp is the hydraulic conductivity of the cell’s membrane, ∆p 
is the change in hydrostatic pressure and ∆π is the change in osmotic pressure. While 
Lp, ∆p and ∆π all affect the resulting flux in water, and hence the change in cell volume, 
in a physiological setting ∆π is the variable with the most potential to change.  
Most animal cells’ membranes are very permeable to water as compared to other 
molecules, meaning the Lp is high. This is because water is small, unlike larger organic 
molecules, and is uncharged, unlike impermeable ions. The Lp is increased in many 
membranes by the presence of aquaporins, which create pores in the cell membrane and 
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facilitate the movement of water (Agre, Brown & Nielson 1995, Echevarria, Windhager, 
Tate & Frindt 1994, Fushimi et al. 1993, Hill 1994). The expression of aquaporins also 
can be regulated and thus effect the ability of water to flux across a cell membrane. In the 
vast majority of circumstances water easily passes through biological membranes and 
thus any change in osmolarity will be followed by the obligatory water flux.  
 Hydrostatic pressure, ∆p, is the physical pressure exerted by water, generally 
generated by gravity or some other physical force, such as hydrostatic pressure that 
moves plasma through the capillary walls. A cell membrane can only withstand a 
hydrostatic pressure gradient of 2 kPa (Guharay 1984). Thermodynamically this is equal 
to an osmotic gradient difference of 1 mOsm. Considering isotonic conditions are about 
290 mOsm, we can calculate that a decrease in extracellular osmolarity of 1 mOsm would 
result in the cell swelling by only 0.35%. When an intact cytoskeleton is present, the 
membrane can withstand greater hydrostatic gradients (Jacobson 1983, Mills 1987). Even 
so, ∆p is only able to play a minimal role in flux of water in or out of an animal cell.  
 ∆π is the difference in osmotic pressure between two solutions separated by a 
semi-permeable membrane. Each solution exerts its own osmotic pressure, and for dilute 
solutions π can be described by the equation: 
 
 π = i · M · R · T 
 
where i is the van’t Hoff factor, M is the molarity of the solution, R is the gas constant 
and T is the absolute temperature. The van’t Hoff factor, named after the equation’s 
creator, is the number of osmotically effective moles of solute actually in solution per 
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mole of solid solute added. In a biological system both i and R are constant. While 
temperature can change, it will generally be the same on either side of the membrane, 
causing no effect to the ∆π. Thus M, the molarity of a solution is the main determinant 
of a solution’s osmotic pressure. As discussed above, any difference in osmotic pressure 
will cause water flux and thus changes in cell volume. If the extracellular solution is 
isotonic with respect to the intracellular solution, the ∆π will equal zero, there will be no 
flux of water and consequently cell volume will remain unchanged.  
 
Steady-State Volume Regulation 
 
 Cell volume regulation is a dynamic process. Even when a cell is under isosmotic 
conditions it must still actively regulate its volume to keep from swelling.  Cells contain a 
cache of various membrane impermeable molecules that increase the intracellular 
osmolarity. Without regulation, these osmolytes would cause the cell to swell. To 
compensate for this, most cells utilize a process that is referred to as the Double Donnan 





to actively pump sodium ions out of the cell and thus decrease the concentration of 
intracellular sodium.  This decrease in sodium concentration helps to balance the 





 ATPase with ouabain causes cell swelling (Lang, Messner & Wang 
1983, MacKnight & Leaf 1988). The intracellular fluid of the cell is initially isosmotic 
with respect to the extracellular fluid because sodium levels are kept low inside the cell, 
but ouabain disables the cell’s mechanism for removing this sodium. As intracellular 
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sodium increases so does the cell’s osmolarity. Thus, water will flux into the cell and it 
will swell.  
 
Cell Volume Regulation 
 
Theoretically a cell will increase in volume proportionally to the ratio in 
osmolarity between the extra and intracellular solutions.  For example, a cell exposed to 
an extracellular solution whose osmolarity is half that of the intracellular solution should 
swell to twice its normal volume.  However, cells do not behave as perfect osmometers. 
One convincing theory proposes that some portion of the cytosol is osmotically inactive, 
possibly due to many water molecules being bound to organic molecules, such as the 
cytoskeleton (Lucke & McCutcheon 1932). Figure 1 illustrates this using a Boyle – van’t 
Hoff Plot. In this figure about 31.8% of the rat hepatocyte cells’ intracellular fluid is 
osmotically inactive.  
Most animal cells have the capacity to regulate their volume. Some of the first 
studies of cell volume regulation were performed in red blood cells. One of the more 
notable studies used duck red blood cells to demonstrate active cell volume regulation in 
anisotonic conditions (Kregenow 1977). A swollen cell actively decreases its volume by 
a process referred to as Regulatory Volume Decrease, or RVD. Similarly, a shrunken cell 
will increase its volume by a process referred to as Regulatory Volume Increase, or RVI. 
Available organic and inorganic osmolytes can be either expelled, in the case of RVD, or 
imported, in the case of RVI, to cause corresponding flux of water and thus return the cell 





Figure 1 Boyle – van’t Hoff plot of rat hepatocyte cell volumes at various 
extracellular osmolarities. With all volume regulatory mechanisms blocked the passive 
changes of rat hepatocyte volumes after 10 min exposure to hypertonicity (327, 360, 400, 
and 450 mOsm/l) are a linear function of the reciprocal of extracellular osmolality. The 
value of 3.33 is equivalent to 300 mOsm/l where cell volumes equal 100%. The intercept 
of the regression line with the volume axis is equivalent to the “osmotically inactive 





processes, the present study focuses on the mechanisms involved in the RVD of 
osmotically swollen cells. (See Wehner et al. 2003 for Review) 
 
Potassium – Chloride Cotransport 
 
 In human glioma cells it was found that 30-40% of cell RVD could be attributed 
to osmolytes moved by KCl cotransport (Ernest, Weaver, Van Duyn & Sontheimer 
2005). KCl cotransport, via the KCC (Potassium-Chloride Cotransporter) family, in 
response to cell swelling has been observed in erythrocytes (Sachs & Martin 1993) as 
well as many other cell types (Thornhill & Laris 1984, Perry & O’Neill 1993, Shen, Chou 
& Ellory 2000, Orlando, Tobey, Wang, Abdulnour-Nakhoul & Orlando 2002, Lauf  & 
Adragna 2000). At present there are four isoforms in the KCC family, KCC1 through 
KCC4. Research indicates that KCC1 (Mount et al. 1999, Su et al. 1999, Mercado, Song, 
Vazquez, Mount & Gamba 2000, Lauf et al. 2001), KCC3 (Mount et al. 1999, Race et al. 
1999) and KCC4 (Mercado et al. 2000) activate during cell swelling while KCC2 does 
not (Payne 1997). KCCs have been shown to be stimulated in many different ways, 
including oxidizing agents and low Mg
2+
 (Lauf & Adragna 2000, Jennings 1999). One 
mechanism of activation for KCCs is dephosphorylation (Lauf and Adragna 2000, 
Jennings & Schultz 1991, Kaji & Tsukitani 1991). Interestingly, phosphorylation is an 
activator of NKCCs (sodium-potassium-chloride cotransporters) that are upregulated 
during RVI. This has led to the proposal of a “phosphorylation – dephosphorylation” 
mechanism to regulate cotransporters in response to cell volume change (Jennings & 





 While the inorganic ions mentioned above are capable mediators of RVD, their 
efflux from the cell interior also can pose problems. Changes in ion concentrations inside 
and outside the cell can affect the function of enzymes and proteins (Andrews, Maughan, 
Nosek & Godt 1991, Yancey, Clark, Hand, Bowlus & Somero 1982). In the brain, 
alterations of ion distribution also can affect neuronal excitability (Iwasa, Tasaki & 
Gibbons 1980).  Uncharged organic osmolyte release does not pose such problems and 
are therefore considered more “compatible” to cell function. These observations have led 
to the “compatible osmolyte” hypothesis, which explains why certain cells use organic 
osmolytes, instead of ions, to achieve volume regulation. It is not surprising that cell 
swelling induces the exit of certain organic osmolytes in many cell types (Yancey et al. 
1982, Hoffman, Lambert & Simonsen 1988, Kinne, Czekay, Grunewald, Mooren & 
Kinne-Saffran 1993, Burg 1995, Burg 1996, Junankar & Kirk 2000). 
 The amino acid taurine is a zwitterion that contributes to RVD in many cell lines, 
such as Ehlich Ascites tumor cells (Hoffman et al. 1988), HeLa cells (Hall, Kirk, Potts, 
Rae & Kirk 1996), C6 glioma cells (Jackson & Strange 1993) and astrocytes (Moran, 
Maar & Pasantes-Morales 1994, Olson 1999). Taurine release is passive; meaning its 
movement follows its electrochemical gradient (Sanchez, Pasantes-Morales, Lazaro & 
Cereijido 1991, Goldstein, Davis-Amara & Musch 1996, Junankar & Kirk 2000) and is 
inhibited by anion channel blockers (Roy & Malo 1992). This suggests that taurine is 
released via an ion channel and not by a transporter. Other types of organic osmolytes are 
also released during RVD. Studies performed in C6 glioma cells (Jackson & Strange 
1993) and rat IMCD cells (Ruhfus, Bauernschmitt & Kinne 1998) demonstrate 
20 
 
hyposmotically induced fluxes of myo-inositol. Sorbitol also has been shown to efflux 
during RVD in C6 cells (Jackson & Strange 1993), rat IMCD cells (Grunewald 1989, 
Ruhfus et al. 1998) and Hela cells (Hall et al. 1996). 
Ion Channel Mediated RVD 
Under certain circumstances, such as ischemia (Askenasy & Navon 1997), a cell may 
encounter extracellular fluid that is significantly lower in osmolarity, and as a result, 
experience an influx of water. The most efficient way for a cell to perform RVD is to 
expel a fraction of the ions that are residing in the intracellular fluid. This will result in 
osmotic water efflux thus maintaining relative volume homeostasis. The fastest way for 
an ion to exit a cell is through a channel, as compared with cotransporter or pumps. Ions 
move passively through channels down their electrochemical gradient. In many cells, 
both chloride and potassium ions are accumulated against their electrochemical gradient 
thus making them optimal choices to facilitate RVD. Most mechanisms of RVD include 
the loss of both potassium and chloride. This coupling of ions for RVD is due in part to 
their opposite charges. Suppose a cell responds to a hyposmotic challenge by increasing 
membrane conductance for potassium, and thus causing potassium to flow out of the cell. 
This increase in potassium conductance also will cause the membrane to hyperpolarize, 
increasing the driving gradient for chloride and leading to chloride efflux.  Similarly, an 
increase in chloride conductance will lead to an increased potassium driving force. (for 
reviews see Lang et al. 1998, Wehner et al. 2003). 
 
Potassium Channels Involved in RVD 
 
 Many potassium channels have been directly or indirectly shown to become 
activated during cell swelling. The BKCa channel, also referred to as the Maxi-K channel, 
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is activated during hyposmotic conditions. BKCa’s activation during swelling has been 
shown in both primary and clonal kidney cultures (Dube, Parent & Suave 1990, Filipovic 
& Sackin 1991, Kawahara, Ogawa & Suzuki 1991, Ling, Webster & Eaton 1992, 
Schlatter 1993, Stoner & Morley 1995, Hirsch & Schlatter 1997, Hafting & Sand 2000). 
BKCa channels are activated by micromolar concentrations of intracellular Ca
2+
 and 
membrane depolarization (Vergara, Latorre, Marrion & Adelman 1998). They exhibit 
large unitary conductances in the range of 100 to 250 pS and are inhibited by tetra-ethyl-
ammonium, TEA (Vergara 1998).  BKCa channels are also activated in cloned kidney 
cells by exogenous ATP (Hafting & Sand 2000, Hafting 2006).  
 IKCa channels have been shown to activate under hyposmostic conditions in T 
lymphocytes (Khanna, Chang, Joiner, Kaczmarek & Schlichter 1999). IKCa channels are 
so called because they exhibit an intermediate unitary conductance that ranges from 20 to 
80 pS. The currents mediated by IKCa are slightly inwardly rectified and Ca
2+
 sensitive. 
These experiments (Khanna et al. 1999) demonstrate hyposmotically induced 
intermediate potassium conductances that were inwardly rectified and Ca
2+
 sensitive. 
Also the conductances were inhibited by the selective IKCa channel blocker clotrimazole 
(Jensen, Stroback, Olesen & Chritophersen 2001 for review).  
 Several other potassium channels exhibit conductances triggered by hyposmotic 
exposure, suggesting they also play a role in RVD. Kv1.3, a voltage-activated delayed-
rectifier channel, is activated during cell swelling and mediates RVD when transfected 
into mouse T lymphocytes (Deutsch & Chen 1993). ISK channel, which is slowly 
activating and usually associates with KVLQT1 to form MinK channels (Barhanin et al. 
1996), is activated in Xenopus oocytes during hyposmotic exposure (Busch, Varnum, 
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Adelman & North 1992). More recently TASK-2 has also been shown to exhibit 
hyposmotically activated conductances in Ehrlich Ascites tumor cells (Niemeyer, Cid, & 
Sepulveda 2001). 
 
Chloride Channels Involved in RVD 
 
 Present research suggests that in most preparations a single chloride (or anion) 
channel type is responsible for the majority of chloride efflux during RVD. This channel 
has been named VSOR, for volume-sensitive outward-rectifying chloride channel 
(Okada, Oiki, Hazama & Morishima 1998), VSOAC, for volume-sensitive organic 
osmolytes-anion channels (Jackson & Strange 1994), or VRAC, for volume-regulated 
anion channel (Nilius & Droogmans 2001). The current mediated by this channel has 
been named ICl,swell (Nilius et al. 1999) and ICl,vol (Hoffman & Mills 1999). VRAC is 
activated in response to hyposmotic exposure in almost all preparations. Although VRAC 
is commonly expressed functionally, its molecular identity has remained a mystery.  
 While the molecular nature of VRAC is unknown, the electrophysiological 
properties of ICl,swell can distinguish it from other known cloned chloride channels. ICl,swell 
has four basic electrophysiological characteristics. First, ICl,swell is outwardly rectified, 
that is, conductance increases at more positive membrane potentials. The second 
characteristic is inactivation of currents elicited at highly positive membrane potentials. 
The degree of inactivation appears to vary by cell type, with the midpoint of inactivation 
occurring at +40 mV in T84 epithelial cells (Braun and Schulman, 1996) and +105 mV 
for myeloma cells (Levitan and Garber, 1995).  The third characteristic is that VRAC has 
an Eisenmen’s Sequence I of ion permeabilities (Nilius & Droogmans 2001), which 
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indicates that the ion flowing through the channel has a weak energy of binding to the 
cationic changes within the channel as compared to the energy needed to unbind the ion 















 > isethionate > gluconate > glycine > taurine 
> aspartate, glutamate. Chloride is the main osmolyte flowing through VRAC in 
conditions established for most electrophysiological studies, however it has been reported 
that cellular release of taurine (Olson & Li 1997) and aspartate (Abdullaev, Rudkauskaya, 
Schools, Kimelberg & Mongin 2006) also occurs via this channel. The fourth 
characteristic, and that for which VRAC got its name, is activation by cell swelling. The 
basal conductance of VRAC is very low, and it is not until swelling has occurred that it is 
activated (Jackson & Strange 1995). 
 A number of cloned chloride channels have been proposed to be the molecular 
source of VRAC currents. ClC-2 is a chloride channel of the ClC gene family that has 
been shown to activate during cell swelling (Grunder, Thiemann, Pusch & Jentz 1992) 
and hyperpolarization (Thiemann, Grunder, Pusch & Jentsch 1992). However, ClC-2 has 





Aspartate (Duan, Ye, Britton, Horowitz & Hume 2000). Another member of the ClC 
family, ClC-3, has many characteristics that are similar to VRAC, such as outward 
rectification and anion selectivity (Strange 1998, Jentsch, Friedrich & Schriever 1999, 
Hume, Duan, Collier, Yamazaki & Horowitz 2000). ClC-3 has a large basal conductance, 
which is in contrast to the very minimal, if any, basal conductance that is demonstrated 
by VRAC. Also, ClC-3 is inhibited by PKC, which has been found to stimulate VRAC 
(Okada et al. 1998, Strange 1998).  
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 Although VRAC seems to be ubiquitously expressed, in certain preparations other 
chloride channels have also activated during hyposmotic exposure. BCl, sometimes 
called maxi Cl
-
, channels are activated by hyposmotic conditions in newborn rat cardiac 
myocytes (Coulombe & Coraboeuf 1992), mouse neuroblastoma cells (Falke & Misler 
1989) and primary cultures of rat cortical astrocytes (Jalonen 1993). SCl, or mini Cl
-
, 
channels have also been observed in Ehlich ascites tumor cells (Christenson & Hoffmann 
1992) and bovine ciliary epithelium (Zhang & Jacob 1997). The calcium activated 
chloride channels, CaCCs, also contribute to RVD (Jentsch 1996, Hoffmann & Mills 
1999, Nilius & Droogmans 2001).  
 
D. Summary of Background Literature 
 
Edema is a common cause of delayed death after traumatic brain injuries and 
stroke (Markiewicz 2006) and astrocytes are commonly observed to swell during those 
situations (Barron et al. 1988, Kimelberg et al. 2000, Mongin & Kimelberg 2005, Somjen 
2004). Astrocyte swelling is thought to cause a decrease in brain ECS and release EAAs 
and other harmful substances in these pathological situations (Sykova & Chvatal 2000). 
Thus research has focused on the mechanisms of RVD in astrocytes. The mysterious 
current ICl,swell is important for RVD and is expressed in astrocytes (Darby et al. 2003, 
Abdullaev et al. 2006). The molecular identity of ICl,swell is not known and the method of 
its activation is poorly understood. It would seem that exogenous ATP, acting via P2Y 
receptors, plays some role in ICl,swell activation. In one study P2Y nucleotide receptors 
play a critical role in the activation of ICl,swell (Darby 2003), however another study 
indicates P2Y receptors only modify its activity (Mongin & Kimelberg 2003). Neither 
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study was able to conclusively answer whether P2Y signaling is necessary or sufficient 




II. Specific Aims 
 
Specific Aim I 
 
 The first goal of this study was to identify and characterize the hyposmotically 
activated current ICl,swell in human 1321N1 astrocytoma cells. This was to be 
accomplished using voltage clamp techniques in both physiological and chloride current-
isolating conditions. ICl,swell  was also identified pharmacologically using the drug DCPIB.  
Specific Aim II 
 
 The second goal of this study was to determine if P2Y receptor expression is 
necessary for ICl,swell activation in human 1321N1 astrocytoma cells. If P2Y receptors 
were found to be associated with ICl,swell activation by hyposmotic exposure (HOE), a 
secondary goal of this aim was to determine which receptor subtype, P2Y1 or P2Y2, is 
responsible. This was to be accomplished using voltage clamp techniques and by 
examining responses to hyposmotic exposure in three subtypes of the 1321N1 cells; one 
with P2Y1 receptor expression, one with P2Y2 receptor expression and another lacking 
P2Y receptor expression. In addition, the drug PPADS was used as a broad spectrum P2Y 
receptor antagonist. 
Specific Aim III 
 
 The final goal of this study was to determine if P2Y receptor activation was 
sufficient to initiate ICl,swell activation in the absence of HOE. This was to be 
accomplished using voltage clamp techniques and by exposing the same cell subtypes 
mentioned above to exogenous ATP under isosmotic conditions. 
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 The materials, equipment and software used during the studies performed for this 
thesis are listed here in alphabetical order. The reader can use this table to find the 
manufacturing company’s name, location and, when available, the item number for each 
product.  
Materials 
Name Item # Company Location 
12 mm Coverslips 12-545-80 Fisher Scientific Pittsburg, PA 
Acrylamide 254 Amresco Solon, OH 
Alexafluor 568 A11036 Invitrogen Carlsbad, CA 
Ammonium Persulfate A3678 Sigma-Aldrich  St. Louis, MO 
-Actin Antibody 600-401-886 Rockland  Philadelphia, 
PA 
BCA* Solutions B9643, C2284 Sigma-Aldrich St. Louis, MO 
CaCl2 133205 J.T. Baker Chemical Co. Phillipsburg, 
NJ 
CsCl C4036 Sigma-Aldrich St. Louis, MO 
CsOH C8518 Sigma-Aldrich St. Louis, MO 
DCPIB* 1540 Tocris Biosciences Ellisville, MO 
Dextrose 1910 J.T. Baker Chemical Co. Phillipsburg, 
NJ 
DMEM* low glucose D5523 Sigma-Aldrich St. Louis, MO 
ECF Western Blotting 
Kit 
RPN5870 Amersham Biosciences Piscataway, NJ 
EGTA* E4378 Sigma-Aldrich St. Louis, MO 
Fetal Bovine Serum  26140-079 Invitrogen Carlsbad, CA 
Geneticin (G418) 15-394N Cambrex East 
Rutherford, NJ 
Glycine G8898 Sigma-Aldrich St. Louis, MO 
Hydrochloric Acid A144Sl-212 Fisher Scientific Pittsburg, PA 




162-0174 Biorad Hercules, CA 
 
KCl P-217 Fisher Scientific Pittsburg, PA 
KH2PO4 P-5379 Sigma-Aldrich St. Louis, MO 
KOH 5-3140 Sigma-Aldrich St. Louis, MO 
Mammalian Cell Lysis 
Kit 
MCL-1 Sigma-Aldrich St. Louis, MO 
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MgCl2 MX0045-1 MCB Reagents  
Microscope slides 48312-003 VWR West Chester, 
PA 
Mounting Media M01 Biomeda Foster City, CA 
Na2ATP A6419 Sigma-Aldrich St. Louis, MO 
Na2HPO4 S-0876 Sigma-Aldrich St. Louis, MO 
NaCl S-9625 Sigma-Aldrich St. Louis, MO 
NaOH S318-3 J.T. Baker Chemical Co. Phillipsburg, 
NJ 
Normal Goat Serum  64292 Invitrogen Carlsbad, CA 
P2Y1 and P2Y2 
Antibodies 
APR-009, APR-010 Alomone Labs Jerusalem, 
Israel 
Paraformaldehyde P6148 Sigma-Aldrich St. Louis, MO 
Penicillin/Streptomycin 15070-063 Invitrogen Carlsbad, CA 
PPADS* P-178 Sigma-Aldrich St. Louis, MO 
Precision Plus Protein 
Ladder 
161-0374 Biorad Hercules, CA 
Protein Standards P0914-5AMP Sigma-Aldrich St. Louis, MO 
SDS* S3771 Sigma-Aldrich St. Louis, MO 
StrepActin AP 161-0382 Biorad Hercules, CA 
Sucrose S5-3 Fisher Scientific Pittsburg, PA 
TEA* T-2265 Sigma-Aldrich St. Louis, MO 
TEMED* 761 Amresco Solon, OH 
Thin Wall Capillary 
Tubes 
TW120F-4 World Precision 
Instruments inc. 
Sarasota, FL 
Trizma Base T1503 Sigma-Aldrich St. Louis, MO 
Trypsin 0.25% 15050 Invitrogen Carlsbad, CA 
Tryton X100 X-100 Sigma-Aldrich St. Louis, MO 
Tween-20 P5927-100mL Sigma-Aldrich St. Louis, MO 
* abbreviations are defined in the abbreviation section below. 
 
Equipment and Software 
 
Axopatch 200A amplifier 200A Axon Instruments  Union City, CA 
Clampex 8.2  Axon Instruments Union City, CA 
Clampfit 8.2  Axon Instruments Union City, CA 
Microsoft Office 2003  Microsoft Redmond, WA 
Narishige PP-83 puller PP-83 Narishige East Meadow, NY 
Nikon Phase-contrast 
Microscope 
TMS-F 211164 Nikon Tokyo, Japan 
Perfusion System CF-8VS Valve 
Assembly 
Cell Micro-Controls Norfolk, VA 
Power Supply PowerPac Basic Biorad Hercules, CA 
Scanning (ECF) Machine FLA-5100 Fujifilm Valhala, NY 
Spectrometer U-2000 Hitachi  Brisbane, CA 
Vapor Pressure 
Osmometer 





 BCA = bicinchoninic acid, DCPIB = 4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-
dihydro-1-ox o-1H-inden-5-yl)oxy]butanoic acid, DMEM = Dulbecco’s modified Eagles 
medium, EGTA = ethylene glycol tetraacetic acid, FBS = fetal bovine serum, HEPES = 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, PPADS = pyridoxalphosphate-6-
azophenyl-2',4'-disulphonic acid, SDS = sodium dodecyl sulfate, TEA = 
tetraethylammonium, TEMED = tetramethylethylenediamine. 
 
C. Cell Culture 
 
Human 1321N1 astrocytoma cells are used throughout these experiments.  As 
originally cloned, this cell line does not express any of the P2Y subtypes (Erb 1995). 
Three genetic variants of the human 1321N1 astrocytoma cell line were obtained from 
Dr. Natalia Chorna of the University of Puerto Rico, San Juan, Puerto Rico. One cell line 
was stably transfected with the P2Y1 receptor subtype (P2Y1 cells), another with the 
P2Y2 receptor subtype (P2Y2 cells), while the third (Parental cells) retained its P2Y 
receptor-lacking genotype (Chorna 2004). Cells transfected with P2Y1 and P2Y2 
receptors also had been simultaneously transfected with resistance to geneticin, an 
antibiotic similar in structure to gentamicin B1 that blocks protein synthesis in both 
prokaryotic and eukaryotic cells. Cells were shipped in large flasks containing 
Dulbecco’s modified Eagle’s medium. Upon arrival cells were replated in small flasks 
and grown to ~90% confluency.  Then they were removed from the culture surface and 
resuspended in media containing DMEM, FBS, glycerol and DMSO before being 
aliquoted into 1 mL cryogenic tubes and frozen for long-term storage in liquid nitrogen. 
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The cells were cultured in growth medium composed of low glucose DMEM 
containing 5% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin. Cells were 
maintained at 37ºC in a humidified atmosphere of 5% CO2 and 95% air. To select for the 
positively transfected cells, P2Y1 and P2Y2 cells were cultured in growth media that also 
contained 0.5 g/L G418. Parental cells were cultured without this drug added. Every 3-4 
days the growth media was replaced. Once ~90% confluency was reached, the cells were 
treated with 0.25% trypsin for 5 to 15 min to loosen the cells from the culture surface and 
the resulting cell suspension was centrifuged. The trypsin solution was removed by 
aspiration and the pellet of cells was resuspended in fresh growth media. A fraction of the 
cells then was replated. Cells for immunostaining and patch clamp experiments were 
grown on cleaned and sterilized 12 mm coverslips under the same conditions.  
 
D. Electrophysiological Recordings 
 
Recording Using PBS as the Extracellular Solution 
 
Astrocytoma cells were plated onto 12 mm diameter glass coverslips at least one 
day prior to recording. Coverslips were placed on a Nikon TMC inverted phase-contrast 
microscope and perfused at a rate of 1-2 mL/sec (35ºC) with a phosphate buffered 
solution (PBS) containing (in mM): NaCl (147), KH2PO4 (0.5), Na2HPO4 (3.2), CaCl2 
(1), MgCl2 (0.5), dextrose (5), KCl (2.7). The pH was adjusted to 7.3 using NaOH. The 
final osmolarity of the solution was determined to be 300 mOsm using a vapor pressure 
osmometer.  Hyposmotic solutions were made by initially adding only 73.5 mM NaCl, 
and then adding NaCl until the final osmolarity was 200 mOsm. Patch pipettes pulled 
from thin-walled glass capillary tubes by a Narishige PP-83 puller and had a resistance of 
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3-9 MΩ when filled with a solution containing (in mM): KCl (135), CaCl2 (0.2), MgCl2 
(1), EGTA (10), Na2ATP (3), HEPES (10), and dextrose (5.5). The free calcium 
concentration was calculated to be 8.9 nM using Maxchelator program WEBMAXCLITE 
v1.15 (http://maxchelator.stanford.edu) and the pH was adjusted to 7.3 using KOH. The 
final osmolarity of the solution was determined to be 300 mOsm using a vapor pressure 
osmometer. The electrode was manipulated so that the tip lightly touched a cell’s 
membrane. Light suction was applied via a syringe, and when the series resistance was 
greater than 1 gigaohm, more negative pressure was applied to break the cell membrane 
inside the electrode. A stable whole-cell recording was defined when the cell had a seal 
resistance between 100 and 500 MΩ and a capacitance between 15 and 80 pF lasting for 
at least five minutes before the experiment was conducted. Stable cells were held in 
voltage clamp mode at a holding potential (VH) of –70 mV using an Axopatch 200A 
amplifier. Every 30 sec, a series of voltage pulses was applied that increased from –100 
mV to +80 mV in 20 mV increments. Pulses were held for 100 msec. For some 
experiments, tetraethylammonium (TEA) or pyridoxalphosphate-6-azophenyl-2',4'-
disulphonic acid (PPADS) was added to the PBS once a stable recording was obtained. 
 
Recording Using CsCl in the Extracellular Solution 
 
Experiments using CsCl solutions were performed in the same manner as those 
done in PBS solution. Both isosmotic and hyposmotic CsCl solutions contained (in mM): 
CsCl (100), HEPES (10), CaCl2 (1), MgCl2 (0.5), and dextrose (5). The pH was adjusted 
to 7.3 using CsOH. For isosmotic CsCl solution, approximately 100 mM sucrose was 
added until the solution had an osmolarity of 300 mOsm. Hyposmotic solutions were 
32 
 
made by adding sucrose until the osmolarity was 200 mOsm. Patch pipettes pulled from 
thin-walled glass capillary tubes by a Narishige PP-83 puller and had a resistance of 3-9 
MΩ when filled with a solution containing (in mM): CsCl (100), CaCl2 (1), MgCl2 (1), 
EGTA (10), Na2ATP (5), HEPES (10), glucose (5.5), and sucrose (100). The free calcium 
concentration was calculated to be 8.9 nM using Maxchelator program WEBMAXCLITE 
v1.15 (http://maxchelator.stanford.edu) and the pH was adjusted to 7.3 using CsOH. The 
final osmolarity of the solution was determined to be 300 mOsm using a vapor pressure 
osmometer. Cell recordings were established with the cells perfused in PBS. Stable cells 
exhibited seal resistances between 100 and 500 MΩ, capacitances between 15 and 80 pF 
and steady resting currents for at least 5 minutes. Once the recording was determined to 
be stable, the extracellular solution was switched to isosmotic CsCl solution and the 
holding voltage was changed to VH = 0 mV. Every 30 seconds a series of voltage pulses 
was applied that increased from –100 mV to +80 mV in 20 mV increments. Pulses were 
held for 100 msec. For some experiments, DCPIB was used during recordings as a 






 Phosphate buffer was made by adding 135 mM NaCl and 2.5 mM Na2HPO4 to 
deionized distilled water (ddH2O) and then adjusting the to a pH to of 7.4 with 1 N HCl. 
Paraformaldehyde fixative solution was made by adding 0.5, 1, 2, or 4% (w/v) 
33 
 
paraformaldehyde to the phosphate buffer. 1% Triton X-100 was made by adding 1% v/v 




 Cells were grown as described above to 60-90% confluence, washed twice with 
phosphate buffer, fixed with 0.5% paraformaldehyde solution for 10 minutes and then 
permeabilized by exposure to 1% Triton X-100 for 5 minutes. Fixed cells were first 
incubated in 20% normal goat serum in phosphate buffer for 30 min before being 
incubated with primary antibody, either rabbit anti-P2Y1 or rabbit anti-P2Y2 diluted to 
1:500 in phosphate buffer, for 1 hr at room temperature. The cells were then washed 
twice and incubated for 5 min with phosphate buffer. The secondary antibody, Alexafluor 
568, was diluted to 1:200 in phosphate buffer and cells were incubated with this solution 
for 1 hr at room temperature. The cells again were washed twice and incubated for 5 
minutes with the phosphate buffer and then washed twice and incubated with ddH2O. 
Coverslips were mounted on microscope slides using aqueous mounting media.  
 For some studies, specific binding was blocked by incubating antibodies with 
control antigen provided by the primary antibody’s manufacturer prior to exposing the 
cells. Using methods provided by the manufacturer (Alomone Labs) control antigen was 
mixed with primary antibody at equal concentrations (w/w) and then incubated for 1 hr at 
room temperature.  The solution then was centrifuged at 10,000 x g for 5 min and the 








 Blocking powder, ECF substrate, secondary antibodies and tertiary antibodies were 
acquired as part of the ECF Western Blotting Kit. Mammalian cell lysis buffer contained 
150 mM NaCl, 50 mM Tris-HCL, 1 mM EDTA, 0.1% SDS, 0.5% DOC, 1% Igepal and a 
cocktail of protease inhibitors supplied in the lysis kit that contained 4-(2-aminoethyl) 
benzenesulfonyl fluoride (AEBSF), pepstatin A, bestatin, leupeptin, aprotinin and trans-
epoxysuccinyl-L-leucyl-amido(4-guanidino)-butane (E-64) Phosphate buffer solution 
(PBS) had a different solute composition than in the electrophysiological studies with (in 
mM) NaCl (147), KH2PO4 (1.5), Na2HPO4 (8), CaCl2 (1), MgCl2 (0.5), dextrose (5) and 
KCl (2.7). Loading buffer was a 50 mM Tris-HCl solution that contained 25% (v/v) 
glycerol, 2% (w/v) SDS, 1% (w/v) bromophenol blue and 5% (v/v) -mecaptoethanol. 
Running buffer was an aqueous solution of 0.1% (w/v) SDS, 0.3% (w/v) trizma base and 
1.44% (w/v) glycine. Transfer buffer was an aqueous solution of 0.05% (w/v) SDS, 0.3% 
(w/v) trizma base and 1.44% (w/v) glycine. Wash buffer was composed of PBS with 3% 





Cells grown in 100 mm culture dishes as described above were lysed using 
Mammalian Cell Lysis Kit. Adherent cells were washed twice with PBS and then 
incubated on ice with 100 µL of Mammalian Cell Lysis buffer for 15 minutes.  Cell 
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debris was extracted by centrifugation at 12,000 x g for 15 minutes. The remaining cell 
lysate solution was pipetted into a 1.5 mL Eppendorf tube and stored at -70º C. 
To determine protein concentration in this solution, the BCA method was used 
with a colorometric kit from Sigma-Aldrich Inc. and the samples and standards measured 
with a spectrophotometer. Briefly, 1 mL of BCA solution was added to each sample and 
standard, and heated at 40ºC for 25 minutes.  The optical density of each standard at 562 
nm then was measured in a spectrophotometer and a regression line was created, with 
typical R
2
 values of > 0.96. Protein standards were made by adding 0, 5, 10, 30 and 50 
µL of 1 mg BSA/ml protein to appropriate amounts of ddH2O to bring the volume to 100 
µL.  Protein samples were made by adding 10 µL of cell lysate to 90 µL of ddH2O. The 
samples were measured under identical conditions and protein concentrations were 




Western blotting was performed to analyze the presence or absence of P2Y 
subtypes in each of the three cell lines. 10% SDS-polyacrylamide gels were made from 
the following reagents (in mL): acrylamide (3.3), ddH2O (4.1), 1.5 M Tris buffer (2.5), 
10% SDS (0.1), TEMED (0.005) and ammonium persulfate (0.05). The stacking gel was 
made with the same ingredients except 0.5 M Tris buffer and 0.01 mL of TEMED were 
used.  
 Loading buffer was added to an equal volume of cell lysate and boiled for 5 min 
prior to loading into the gel. A protein ladder was placed in separate lanes of the gel.  The 
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Power Pac Basic power supply was set at 50 mA until the samples had run through the 
stacking gel and then increased to 100 mA for one to two hours.  
 
Western Transfer and Imaging 
 
Protein contents of the gel were transferred to a polyvinylidene difluoride (PVDF) 
membrane using electrophoresis. The transfer was run overnight at 90 mA. After transfer, 
the membrane was washed with wash buffer and incubated in 5% blocking solution for 1 
hr. Primary antibodies were diluted into 5% blocking buffer and incubated for one hr. 
Anti-β-Actin was used at a dilution of 1:1000 and both Anti-P2Y1 and Anti-P2Y2 were 
used at a dilution of 1:200.  After incubation with the primary antibody the membrane 
was washed twice for 10 min with wash buffer. FITC-conjugated secondary antibody was 
diluted to 1:600 with wash buffer and incubated with the membrane for one hr. 
StrepTactin AP-conjugate was added at a 1:5000 concentration at the same time as the 
secondary antibody to label the protein ladder. The alkaline-phosphatase-conjugated 
tertiary antibody to fluorescein was diluted to 1:1000 in wash buffer and incubated with 
the membrane for 30 min. The membrane then was washed using wash buffer a final 
time. ECF substrate was added to the membrane, which then was immediately placed into 
the ECF scanning machine. Fluorescence was excited at 488 nm and the emission was 
recorded with a digital imaging system. The resulting image was viewed and edited on 
Micrososoft Picture Manager. 
 At times, control antigens were preincubated with the P2Y antibodies to test for 
cross reactivity of the primary antibodies. Protocol for incubation with control antigen is 
described in section III.E. Immunostaining. 
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G. Data Analysis and Calculations 
 
Electrophysiological raw data were recorded using Clampex 8.2 (Axon 
Instruments) and then transferred to Excel (Microsoft) for graphical analysis. 
Calculations made from these data include the reversal potential, cell conductance and 
current inhibition. Both reversal potential and conductance were determined by 
calculating the equation for a line connecting data points on either side of the voltage axis 
(e.g. Figure 2). The slope of this line was used as an estimate of cell slope conductance 
and the intercept of this line on the voltage axis was used as an estimate of the membrane 
reversal potential. 
 
Calculating TEA Current Inhibition 
 
The magnitude of current inhibition by TEA was calculated using Microsoft 
Excel using current-voltage plots of the data before the addition of TEA (blue) and after 
the application of 10 mM TEA to the bath solution (red) as shown in Figure 3. Since TEA 
inhibited only the outward rectifying component of the cell conductance, currents were 
measured at +80 mV.  The total current prior to TEA treatment (IT) and the current 
remaining after TEA treatment (ID) were compared to the extrapolated-baseline current at 
+80 mV (IEB). IEB was estimated by calculating a linear regression line using the currents 
measured at -100 mV, -80 mV and -60 mV. The calculation of percent TEA-current 
inhibition is performed as follows: 
 
Percent TEA-current inhibition = [(IT – ID)/(IT – IEB)] x 100% 
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Figure 2 Example of cell reversal potential and conductance analysis. The blue data 
set contains currents measured from a cell in isosmotic CsCl (II). The pink data set 
contains currents from the same cell 5 min after the bath solution was changed to 
hyposmotic CsCl solution (IH). The yellow data set contains the currents resulting from 
hyposmotic CsCl solution plus 20 M DCPIB (ID). Lines segments between currents on 
either side of the abscissa were constructed for each data set. These lines were used to 






















Calculating Drug-induced Current Inhibition 
 
 Both PPADS and DCPIB were used to inhibit hyposmotically activated current. 
The magnitude of current inhibition by these drugs was calculated using Microsoft Excel 
to create a current-voltage plot of the data as shown in Figure 2. Currents elicited during 
isosmotic CsCl conditions (II), hyposmotic CsCl conditions (IH) and hyposmotic CsCl 
conditions plus 20 µM DCPIB (ID) are represented by the blue, pink and yellow data sets, 
respectively. The calculation of percent drug-induced current inhibition is as follows: 
 




Data were analyzed by ANOVA, or Students t-test for paired or unpaired samples, 
as appropriate and significance indicated for p<0.05. All values a reported as the mean ± 
SEM. Clampfit 8.2 (Axon Instruments) was used for electrical recording analysis and 




Figure 3 Example of cell membrane current analysis. The blue data set contains 
currents measured from a cell in isosmotic PBS without TEA. The red data set contains 
currents from the same cell 5 min after application of isosmotic PBS with 10 mM TEA. 
Data points for membrane voltages of -100 mV to -60 mV without TEA were used to 
create the line that represents non-rectified current for cells in isosmotic conditions. The 
equation for this line is displayed in the bottom right hand corner. Also on the right are 
indicators of the extrapolated-baseline current at +80 mV, IEB, TEA-inhibited current, ID, 
and total current, IT, used in calculations as described in the text.  
  























A. 1321N1 Human Astrocytoma Cells Exhibit TEA Sensitivity 
 
 Whole cell voltage clamp recordings in isosmotic PBS revealed a number of basal 
electrophysiological attributes of 1321N1 astrocytoma cells. Under these conditions 
P2Y1 and P2Y2 cells had similar basal whole-cell slope conductances, measured at 0 pA 
and normalized to the cell capacitance of 0.1135 ± 0.0301 nS/pF and 0.1060 ± 0.0186 
nS/pF, respectively.  Parental cells averaged a larger basal conductance of 0.2887 ± 
0.1419 nS/pF, although it was not significantly different from the receptor expressing 
cells (p = 0.33) (Figure 4A). Reversal potentials were quite negative for each cell type. 
P2Y1, P2Y2 and Parental cells averaged reversal potentials of -68.4 ± 3.3 mV, -68.1 ± 
7.0 mV and -60.5 ± 5.6 mV (Figure 4B). All cells studied had capacitances between 10 
and 60 pF. 
 All three cell lines exhibited TEA-sensitive outwardly rectified currents while 
perfused with isosmotic PBS, although in parental cells this was not statistically 
significant. 10 mM TEA inhibited currents measured at +80 mV by 88.3 ± 9.2% 77.9 ± 
10.1%, and 28.4 ± 24.4% in P2Y1, P2Y2 and Parental cells, respectively (Figure 5A). 
Figure 5B shows the TEA dose-response curve in P2Y1 cells. The curve was fit using the 
Michaelis-Menten equation with a calculated IC50 of 0.37 mM and maximal inhibition of 
88%.  
 During perfusion with 10 mM TEA whole cell normalized conductance and 
reversal potential were measured in each cell type. After the addition of TEA there was 
no significant change in slope conductance in P2Y1 (p = 0.13), P2Y2 (p = 0.46) or 






Figure 4 The effect of TEA on whole cell conductance and reversal potential in 
1321N1 astrocytoma cells. A) Whole cell normalized slope conductance for P2Y1 
(n=8), P2Y2 (n=7) and Parental (n=4) cells during perfusion with isosmotic PBS and 
isosmotic PBS plus 10 mM TEA. B) Reversal potentials for P2Y1 (n=8), P2Y2 (n=7) and 








Figure 5 Effect of TEA on outwardly-rectified potassium currents in 1321N1 
astrocytoma cells. A) Percent of current inhibited at +80 mV by TEA in isosmotic PBS.  
Measurements were taken at +80 mV in P2Y1 receptor transfected cells (n=8), P2Y2 
receptor transfected cells (n=7) and Parental cells (n=4). (* indicates p < 0.05) B) TEA 
concentrations of 0.5 mM (n=3), 1 mM (n=3), 5 mM (n=4) and 10 mM (n=8) were used 
to inhibit outwardly rectified potassium currents in P2Y1 receptor transfected cells in 
isosmotic PBS. The curve was fit using first order kinetics equation calculated assuming 
the curve passes through the origin (r
2
 = 0.81). The IC50 was determined to be 0.37 mM. 































































change after application of TEA in P2Y1 (p = 0.69), P2Y2 (p = 0.46) or Parental cells (p 
= 0.79). 
B. Current activated in hyposmotic PBS is PPADS-sensitive in cells 
expressing P2Y receptors. 
 
 The electrophysiological response to hyposmotic exposure (HOE) and subsequent 
addition of 100 µM PPADS, a specific nucleotide receptor blocker, was examined in each 
cell type by voltage clamp technique in PBS. Isosmotic and hyposmotic PBS had 
osmolarities of 300 mOsm and 200 mOsm, respectively, and in all conditions, 10 mM 
TEA was present as discussed in Materials and Methods. Raw electrophysiological data 
for typical P2Y1, P2Y2 and Parental cells are shown in Figures 6, 7, and 8, respectively. 
P2Y1 and P2Y2 cells exhibited similar electrophysiological responses to HOE. Both cell 
types demonstrated an increase in current amplitude within 5 to 10 min of HOE that was 
inhibited by 100 µM PPADS (Figures 6A and 7A). The hyposmotically activated currents 
in P2Y1 and P2Y2 cells were outwardly rectified (Figures 6E and 7E) and also showed 
time inactivation at depolarizing potentials (Figures 6C and 7C). While Parental cells also 
increased in current after HOE, they demonstrated no outward rectification, time 
inactivation or sensitivity to PPADS (Figure 8).  
 Cumulative data from these experiments allowed for analyses of the 
hyposmotically activated conductance and change in reversal potential. All cell types 
increased their whole-cell normalized slope conductance during HOE, measured at 0 pA, 
with Parental cells nearly doubling and receptor expressing cells more than doubling 





Figure 6 P2Y1 receptor transfected cells have a hyposmotically activated current 
that is inhibited by 100 µM PPADS in PBS. A) Illustrated is a strip chart derived from 
data obtained from a P2Y1 cell initially bathed in isosmotic PBS.  TEA (10 mM) was 
added to the perfusate as indicated and the cell was subsequently exposed to hyposmotic 
PBS and then hyposmotic PBS plus 100 µM PPADS. Cell currents recorded while the 
cell was perfused with B) isosmotic PBS, C) hyposmotic PBS and D) hyposmotic PBS 
plus 100 µM PPADS. Location of current traces in the strip chart is similarly indicated. 





Figure 7 P2Y2 receptor transfected cells have a hyposmotically activated current 
that is inhibited by 100 µM PPADS in PBS. A) Illustrated is a strip chart derived from 
data obtained from a P2Y2 cell initially bathed in isosmotic PBS.  TEA (10 mM) was 
added to the perfusate as indicated and the cell was subsequently exposed to hyposmotic 
PBS and then hyposmotic PBS plus 100 µM PPADS. Cell currents recorded while the 
cell was perfused with B) isosmotic PBS, C) hyposmotic PBS and D) hyposmotic PBS 
plus 100 µM PPADS. Location of current traces in the strip chart is similarly indicated. 





Figure 8 Parental cells have a hyposmotically activated current that is not inhibited 
by 100 µM PPADS in PBS. A) Illustrated is a strip chart derived from data obtained 
from a Parental cell initially bathed in isosmotic PBS.  TEA (10 mM) was added to the 
perfusate as indicated and the cell was subsequently exposed to hyposmotic PBS and then 
hyposmotic PBS plus 100 µM PPADS. Cell currents recorded while the cell was perfused 
with B) isosmotic PBS, C) hyposmotic PBS and D) hyposmotic PBS plus 100 µM 
PPADS. Location of current traces in the strip chart is similarly indicated. E) Current-








Figure 9 Effects of TEA, hyposmotic exposure and PPADS on whole cell 
conductance and reversal potential in 1321N1 astrocytoma cells. A) Whole cell 
normalized conductance for P2Y1 (n=4), P2Y2 (n=4) and Parental (n=4) cells during 
perfusion with isosmotic PBS plus 10 mM TEA, hyposmotic PBS plus 10 mM TEA and 
hyposmotic PBS plus 10 mM TEA and 100 µM PPADS. B) Reversal potentials for P2Y1 
(n=4), P2Y2 (n=4) and Parental (n=4) cells during perfusion with isosmotic PBS plus 10 
mM TEA, hyposmotic PBS plus 10 mM TEA and hyposmotic PBS plus 10 mM TEA 

































































depolarized (p = 0.0064 and 0.0458, respectively) during HOE, while the reversal 
potential of Parental cells did not depolarize (Figure 9B). 
The addition of 100 µM PPADS to hyposmotic medium had no significant effect 
on whole cell conductance or reversal potential, but did inhibit current at higher voltages 
in P2Y1 and P2Y2 cells (Figure 9). Whole-cell normalized slope conductance of both 
P2Y1 and P2Y2 cells showed no significant change (p = 0.4708 and 0.3202, respectively) 
after the addition of PPADS to the hyposmotic PBS. Similarly, P2Y1 and P2Y2 cells 
demonstrated no significant change (p = 0.3542 and 0.1446, respectively) in reversal 
potential in response to the drug application. However, when the current elicited by HOE 
was measured at +80 mV there was a significant inhibition of current in P2Y1 and P2Y2 
cells of 57.3 ± 8.3% and 51.2 ± 10.1%, respectively. The extent of inhibition at higher 
voltages in these cell types also can be seen in the current-voltage plots in Figures 6C and 
7C. The Parental cells showed no change whole-cell conductance, reversal potential or 
current at depolarized potential in response to PPADS (Figures 9 and 10).  
 In separate experiments P2Y1 and P2Y2 cells were perfused with 100 µM 
PPADS prior to HOE (Figures 11-13). Strip chart recordings (Figures 11A and 12A) 
demonstrated little increase in current amplitude during HOE. The inactivation seen in 
previous experiments (Figures 6 and 7) was also absent in the presence of PPADS 
(Figures 11C and 12C). Whole cell conductance did increase during HOE in the presence 
of PPADS (Figure 13A),but not significantly, and definitely not to the same extent as 
without PPADS. Also, in the presence of PPADS there is no significant change in 
reversal potential due to HOE in either receptor cell type (Figure 13B).  In P2Y1 and 





Figure 10 PPADS inhibits hyposmotic current in P2Y1 and P2Y2 receptor 
transfected cells but not in Parental cells in PBS. Percent inhibition of hyposmotically 
activated current, measured at +80 mV, by 100 µM PPADS in P2Y1 (n=4), P2Y2 (n=4) 
and Parental (n=4) cells. Cells were perfused in PBS solution as described in the 
Materials and Methods section and subjected to hyposmotic exposure for 5-10 min prior 





































Figure 11 P2Y1 receptor transfected cells lack hyposmotically activated current 
when treated with 100 µM PPADS prior to hyposmotic exposure. A) Illustrated is a 
strip chart derived from data obtained from a P2Y1 cell initially bathed in isosmotic PBS.  
TEA (10 mM) was added to the perfusate as indicated and the cell was subsequently 
exposed to isosmotic PBS plus 100 µM PPADS and then hyposmotic PBS plus 100 µM 
PPADS. Cell currents recorded while the cell was perfused with B) isosmotic PBS, C) 
isosmotic PBS plus 100 µM PPADS and D) hyposmotic PBS plus 100 µM PPADS. 
Location of current traces in the strip chart is similarly indicated. E) Current-voltage 







Figure 12 P2Y2 receptor transfected cells lack hyposmotically activated current 
when treated with 100 µM PPADS prior to hyposmotic exposure. A) Illustrated is a 
strip chart derived from data obtained from a P2Y2 cell initially bathed in isosmotic PBS.  
TEA (10 mM) was added to the perfusate as indicated and the cell was subsequently 
exposed to isosmotic PBS plus 100 µM PPADS and then hyposmotic PBS plus 100 µM 
PPADS. Cell currents recorded while the cell was perfused with B) isosmotic PBS, C) 
isosmotic PBS plus 100 µM PPADS and D) hyposmotic PBS plus 100 µM PPADS. 
Location of current traces in the strip chart is similarly indicated. E) Current-voltage 
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Figure 13 Reversal potentials for P2Y1 and P2Y2 receptor transfected cells do not 
depolarize when treated with 100 µM PPADS prior to hyposmotic exposure. A) 
Calculated whole cell conductance for P2Y1 (n=3) and P2Y2 (n=3) cells during 
perfusion with isosmotic PBS plus 10 mM TEA, isosmotic PBS plus 10 mM TEA and 
100 µM PPADS and hyposmotic PBS plus 10 mM TEA and 100 µM PPADS. B) 
Calculated reversal potentials for P2Y1 (n=3) and P2Y2 (n=3) cells during perfusion with 
isosmotic PBS, isosmotic PBS plus 10 mM TEA, isosmotic PBS plus 10 mM TEA and 
100 µM PPADS and hyposmotic PBS plus 10 mM TEA and 100 µM PPADS. C) Change 
in reversal potential for all three cell lines in response to hyposmotic exposure. White 
bars are responses to hyposmotic exposure without PPADS in bath solution. Black bars 






0.0091 and 0.0071, respectively) the depolarization seen when these cells experience 
HOE without added drug (Figure 13C). 
 
C. Current activated in hyposmotic CsCl solution is DCPIB-sensitive 
 The protocol for recording from cells in the CsCl solution was very similar to that 
of the PBS experiments, with the exceptions that 100 mM sucrose was a major osmolyte 
and the holding potential was 0 mV. In order to better isolate anion currents 1321N1 
astrocytoma cells were recorded using bath and pipette solutions with 100 mM CsCl , 
replacing the NaCl and KCl used in PBS (for more information on CsCl solution contents 
see Materials and Methods). Since all major ions were distributed equally the across the 
cell membrane the reversal potential during whole cell recording was close to 0 mV. 
Thus the holding was also set to 0 mV in order to limit the amount of injected holding 
current.  
 Raw electrophysiological data for P2Y1, P2Y2 and Parental cells are shown in 
Figures 14, 15, and 16, respectively. P2Y1 and P2Y2 cells exhibit similar 
electrophysiological responses to HOE with an increase in current amplitude (Figures 14 
and 15). Red lines in Figures 14E and 15E represent the difference between currents 
generated under isosmotic and hyposmotic conditions. These current voltage plots 
reverse just below and just above 0 mV for P2Y1 and P2Y2 cells, respectively. P2Y2 
cells also expressed some degree of outward rectification (Figure 15E). Parental cells did 
not consistently demonstrate an increase in amplitude due to HOE (Figure 16).  
 The hyposmotically activated conductance in P2Y1 and P2Y2 cells was inhibited 




Figure 14 P2Y1 receptor transfected cells exhibit a hyposmotically activated 
chloride current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart 
derived from data obtained from a P2Y1 cell initially bathed in isosmotic CsCl solution 
(300 mOsm).  The cell was subsequently exposed to hyposmotic CsCl solution (200 
mOsm) and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents 
recorded while the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl 
solution and D) hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces 
in the strip chart is similarly indicated. E) Current-voltage relationships for the three 
current traces in B) through D) are displayed in black. The red plot represents the 





Figure 15 P2Y2 receptor transfected cells exhibit a hyposmotically activated 
chloride current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart 
derived from data obtained from a P2Y2 cell initially bathed in isosmotic CsCl solution 
(300 mOsm).  The cell was subsequently exposed to hyposmotic CsCl solution (200 
mOsm) and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents 
recorded while the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl 
solution and D) hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces 
in the strip chart is similarly indicated. E) Current-voltage relationships for the three 
current traces in B) through D) are displayed in black. The red plot represents the 





Figure 16 Flat Parental cells do not exhibit a hyposmotically activated chloride 
current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart derived from 
data obtained from a flat Parental cell initially bathed in isosmotic CsCl solution (300 
mOsm).  The cell was subsequently exposed to hyposmotic CsCl solution (200 mOsm) 
and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents recorded while 
the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl solution and D) 
hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces in the strip 
chart is similarly indicated. E) Current-voltage relationships for the three current traces in 








Figure 17 DCPIB inhibits hyposmoticly-activated chloride current in P2Y1 and 
P2Y2 receptor transfected cells but not in flat Parental cells. A) Calculated whole cell 
conductance for P2Y1 (n=4), P2Y2 (n=4) and Parental (n=2) cells during perfusion with 
isosmotic CsCl, hyposmotic CsCl and hyposmotic CsCl plus 20 µM DCPIB. B) Percent 
inhibition of hyposmotically activated current, measured at +80 mV, by 20 µM DCPIB in 
P2Y1 (n=4), P2Y2 (n=4) and Parental (n=2) cells. Cells chosen for these experiments 
were identified as morphologically “flat” visually by phase-contrast microscopy. Cells 
were then perfused in CsCl solution as described in the Materials and Methods section 
and subjected to hyposmotic exposure for 5-10 mins prior to addition of DCPIB. (* 
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Average whole cell normalized conductance for P2Y1 and P2Y2 cells increased from 
0.0850 ± 0.0162 nS/pF and 0.0747 ± 0.0201 nS/pF to 0.1628 ± 0.0442 nS/pF and 0.1235 
± 0.0247 nS/pF, respectively. Subsequent application of DCPIB caused a decrease in 
conductance to 0.1233 ± 0.0298 nS/pF and 0.0760 ± 0.0232 nS/pF for P2Y1 and P2Y2 
cells, respectively. The hyposmotically activated current, measured at +80 mV, was 
reduced by 32.6 ± 7.6% and 75.2 ± 10.1% for P2Y1 and P2Y2 cells, respectively (Figure 
17B). Parental cells did not experience any decrease in conductance or current as a result 
of DCPIB application (Figure 17).  
 Initial experiments targeted cells that were morphologically flat (Figures 14-17). 
This choice made acquiring a stable voltage clamp recording difficult to obtain and in the 
case of Parental nearly impossible (note the n = 2 for flat Parental cells in Figure 17). 
Thus, an additional subset of morphologically rounder cells was chosen for analysis. 
Different results were obtained when recording from round compared with flat Parental .  
 Raw electrophysiological data for round P2Y1 and Parental cells are shown in 
Figures 18 and 19, respectively. Rounded P2Y1 and Parental cells exhibited similar 
electrophysiological responses to HOE with an increase in current amplitude. Red lines in 
Figures 18E and 19E represent the difference between currents generated under 
hyposmotic and hyposmotic plus DCPIB conditions for P2Y1 and Parental cells, 
respectively. These currents demonstrated outward rectification and reversal potentials 
just above 0 mV for both P2Y1 and Parental cells.  
 The hyposmotically activated conductance in round P2Y1 and Parental cells was 
inhibited by bath application of 20 µM DCPIB (Figure 20A). Average whole cell 




Figure 18 Rounded P2Y1 receptor transfected cells exhibit a hyposmotically 
activated chloride current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip 
chart derived from data obtained from a P2Y1 cell initially bathed in isosmotic CsCl 
solution (300 mOsm).  The cell was subsequently exposed to hyposmotic CsCl solution 
(200 mOsm) and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents 
recorded while the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl 
solution and D) hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces 
in the strip chart is similarly indicated. E) Current-voltage relationships for the three 
current traces in B) through D) are displayed in black. The red plot represents the 






Figure 19 Rounded Parental cells exhibit a hyposmotically activated chloride 
current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart derived from 
data obtained from a Parental cell initially bathed in isosmotic CsCl solution (300 
mOsm).  The cell was subsequently exposed to hyposmotic CsCl solution (200 mOsm) 
and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents recorded while 
the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl solution and D) 
hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces in the strip 
chart is similarly indicated. E) Current-voltage relationships for the three current traces in 
B) through D) are displayed in black. The red plot represents the difference in current 








Figure 20 DCPIB inhibits hyposmotic-induced current in rounded P2Y1 and 
Parental cells in CsCl solution. A) Calculated whole cell conductance for P2Y1 (n=3) 
and Parental (n=4) cells during perfusion with isosmotic CsCl, hyposmotic CsCl and 
hyposmotic CsCl plus 20 µM DCPIB. B) Percent inhibition of hyposmotically activated 
current, measured at +80 mV, by 20 µM DCPIB in P2Y1 (n=3) and Parental (n=4) cells. 
Cells chosen for these experiments were identified as morphologically rounded. Cells 
were then perfused in CsCl solution as described in the Materials and Methods section 































































0.0430 nS/pF and 0.0725 ± 0.0068 nS/pF to 0.3493 ± 0.0179 nS/pF and 0.4782 ± 0.1102 
nS/pF, respectively. Subsequent application of DCPIB during HOE caused a decrease in 
conductance to 0.0883 ± 0.0296 nS/pF and 0.1393 ± 0.0251 nS/pF for round P2Y1 and 
Parental cells, respectively. The hyposmotically activated current, measured at +80 mV, 
was reduced by 103 ± 0.8% and 101 ± 5.6% for P2Y1 and Parental cells, respectively in 
the presence of DCPIB (Figure 20B). 
 
D. Exogenous ATP activates a DCPIB-insensitive chloride conductance 
 
 The effect of exogenous 1 mM ATP was analyzed under CsCl conditions in the 
three cell types (Figures 21 – 24).  Raw electrophysiological data showed an increase in 
current amplitude in both P2Y1 and P2Y2 cells after exposure to 1 mM ATP (Figures 21 
and 22). This current exhibited inward rectification, a reversal potential near 0 mV and 
insensitivity to 20 µM DCPIB. Parental cells did not exhibit an increase in current 
amplitude when exposed to exogenous ATP (Figure 23). 1 mM ATP caused normalized 
whole-cell conductance increases from 0.1107 ± 0.0367 nS/pF to 0.1983 ± 0.0304 nS/pF 
in P2Y1 cells and 0.0680 ± 0.0246 nS/pF to 0.1130 ± 0.0551 nS/pF in P2Y2 cells, 
respectively, while Parental cells showed no increase (Figure 24). Initial experiments 
using micromolar concentrations of exogenous ATP showed no change in current. Also, 
P2Y1 cells (n=2) exposed to 500 µM ATP activated current of amplitude only 10% of the 




Figure 21 Exogenous ATP activates an inwardly rectified, DCPIB-insensitive 
chloride current in P2Y1 receptor transfected cells. A) Illustrated is a strip chart 
derived from data obtained from a P2Y1 cell initially bathed in isosmotic CsCl solution 
(300 mOsm).  The cell was subsequently exposed to 1 mM ATP (200 mOsm) and then 1 
mM plus 20 µM DCPIB. Cell currents recorded while the cell was perfused with B) 
isosmotic CsCl, C) 1 mM ATP in isosmotic CsCl and D) 1 mM ATP in isosmotic CsCl 
solution plus 20 µM DCPIB. Location of current traces in the strip chart is similarly 
indicated. C) Current-voltage relationships for the three current traces B) through D) are 
displayed in black. The red plot represents the difference in currents elicited in the 





Figure 22 Exogenous ATP activates an inwardly rectified, DCPIB-insensitive 
chloride current in P2Y2 receptor transfected cells. A) Illustrated is a strip chart 
derived from data obtained from a P2Y2 cell initially bathed in isosmotic CsCl solution 
(300 mOsm).  The cell was subsequently exposed to 1 mM ATP (200 mOsm) and then 1 
mM plus 20 µM DCPIB. Cell currents recorded while the cell was perfused with B) 
isosmotic CsCl, C) 1 mM ATP in isosmotic CsCl and D) 1 mM ATP in isosmotic CsCl 
solution plus 20 µM DCPIB. Location of current traces in the strip chart is similarly 
indicated. C) Current-voltage relationships for the three current traces B) through D) are 
displayed in black. The red plot represents the difference in currents elicited in the 






Figure 23 Exogenous ATP does not activate any chloride current in round Parental 
cells. A) Illustrated is a strip chart of a Parental cell that is initially bathed in isosmotic 
(300 mOsm) CsCl solution and is subsequently treated with 1 mM ATP. Cell currents 
recorded while the cell is perfused with B) isosmotic CsCl solution and C) isosmotic 
CsCl solution containing 1 mM ATP. Location of current traces in the strip chart is 




Figure 24 Exogenous ATP activates a chloride conductance in P2Y1 and P2Y2 
receptor transfected cells, but not in Parental cells. A) Normalized conductance 
during perfusion of isosmotic CsCl solution (Iso) and isosmotic CsCl solution plus 1 mM 
ATP (ATP) in P2Y1 (n=3), P2Y2 (n=3) and Parental cells (n=3). Cells were then 
perfused in CsCl solution as described in the Materials and Methods section and 





E.  Western Blotting 
 
 Western blotting confirms P2Y1 and P2Y2 receptor expression in P2Y1 and 
P2Y2 cells, but not in Parental cells. All cell lysates showed staining for Anti--actin 
protein in both western blots shown (Figures 25 and 26). P2Y1 receptor bands in  
the 90 kD range can be seen in both P2Y1 and P2Y2 cell lanes (Figure 25). P2Y2 
receptor antibody generates similar results, with both P2Y1 and P2Y2 cells producing 
bands above 90 kD (Figure 26). These bands are in the same kD range as described by 
the antibody manufacturer (Alomone Labs) for human platelets. In an effort to inhibit 
cross-reactivity between the two subtypes P2Y1 and P2Y2 receptor antibodies were pre-
incubated with P2Y2 and P2Y1 peptide antigen, respectively, prior to use, as described in 
the Materials and Methods section. Even under these circumstances bands were observed 
in P2Y2 cell lysates when incubated with P2Y1 receptor antibody (Figures 25) and in 




 Initial experiments were performed under fixatives of 4, 2, 1 and 0.5% 
paraformaldehyde solution. Similar intensities of receptor staining were found in each for 
each fixing solution used (data not shown). Minimal fixation was desired, as the P2Y1 
and P2Y2 receptor antibodies were derived from antigens in their native form, and thus 
0.5% paraformaldehyde was used in subsequent studies.  
 All 1321N1 cell types were analyzed immunocytochemically for both P2Y1 and 







Figure 25 P2Y1 receptor expression in 1321N1 cell lines. Western blot probed with 
anti-P2Y1 and anti--Actin as the primary antibodies. The anti-P2Y1 antibody was 
incubated with P2Y2 peptide antigen prior to use as described in the Materials in 













Figure 26 P2Y2 receptor expression in 1321N1 cell lines. Western blot probed with 
anti-P2Y2 and anti--Actin as the primary antibodies. The anti-P2Y2 antibody was 
incubated with P2Y1 control peptide prior to use as described in the Materials in Methods 
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results (Figure 27A). However, anti-P2Y2 antibody also stained P2Y1 cells, albeit to a 
lesser degree (Figure 27D). Pre-incubation, with P2Y1 control antigen as described in the 
Materials and Methods, still yielded positive labeling with P2Y1 and P2Y2 receptor 
antibody (Figure 27B and 27E, respectively). The level of staining when P2Y2 control 
antigen was pre-incubated with P2Y2 receptor antibody was not visibly different than 
when P2Y2 receptor antibody was used alone (Figure 27F). When no primary antibody 
was used (the negative control) there was almost no staining of the P2Y1 cells (Figure 
27C).  
 Similarly, P2Y2 cells were analyzed for both P2Y1 and P2Y2 receptor 
expression. P2Y2 cells exhibited staining when exposed to anti-P2Y2 (Figure 28A) and 
anti-P2Y1 receptor antibody (Figure 28D). Pre-incubation of either of these antibodies 
with P2Y2 control antigen did not decrease the level of staining (Figures 28B and E). 
Staining of P2Y2 cells with P2Y1 receptor antibody that was pre-incubated with P2Y1 
control antigen did reduce staining to control levels (Figure 28F). When no primary 




    
 
    
 
    
Figure 27 Immunostaining of P2Y1 cells. A) P2Y1 cells stained using P2Y1 antibody, 
B) P2Y1 antibody pre-absorbed with P2Y1 peptide antigen, C) no primary antibody, D) 
P2Y2 antibody, E) P2Y2 antibody pre-absorbed with P2Y1 peptide antigen, F) and P2Y2 








    
 
    
 
    
Figure 28 Immunostaining of P2Y2 cells. A) P2Y2 cells stained using P2Y2 antibody, 
B) P2Y2 antibody pre-absorbed with P2Y2 peptide antigen, C) no primary antibody, D) 
P2Y1 antibody, E) P2Y1 antibody pre-absorbed with P2Y2 peptide antigen, F) P2Y1 









A. Results Summary and Conclusions 
 
 Initial recordings suggested cells perfused with PBS activated a chloride 
conductance in response to HOE. Presence of ICl,swell was then confirmed in the CsCl 
experiments. Not only did the hyposmotically activated current demonstrate 
electrophysiological characteristics of ICl,swell, but it also was potently inhibited by 
DCPIB, a selective ICl,swell blocker (Decher et al. 2001). Experiments on rounded cells 
perfused with CsCl solution demonstrated that P2Y receptor expression is not necessary 
for ICl,swell activation. ICl,swell was activated just as potently in round Parental cells as in the 
P2Y1 or P2Y2 cells. A chloride current was activated by extracellular ATP, however it 
did not demonstrate the electrophysiological characteristics typically ascribed to ICl,swell. 
Previous literature describes an ATP activated chloride current with a pharmacological 
profile similar to that of the P2Y1 receptor subtype (Darby et al. 2003). Our studies 
indicate that both P2Y1and P2Y2 receptors are capable of activating the ATP induced 
current. These results are based on the P2Y receptor expression reported from the 
suppliers, however the immunocytochemical and western data in this study are 
contradictory to those reports. It is clear that at least one of the receptor subtypes, P2Y1 
or P2Y2, are responsible for the current activation, however, until receptor expression is 




B. Electrophysiological Characteristics and TEA sensitivity of 1321N1 
Human Astrocytoma Cells in Isosmotic PBS 
 
 Before analyzing the electrophysiology of the 1321N1 cells it is important to 
recognize the conditions under which they were studied. All studies were performed in 
vitro. Phosphate buffered saline (PBS) was used as an extracellular medium and I 
designed the pipette solution to closely resemble physiological intracellular conditions. 
All electrophysiological studies were performed using voltage clamp procedures. Such 
recordings do not give exact resting membrane potentials; however, comparisons 
between interpolated reversal potentials under different conditions can reveal changes in 
relative conductances for the ions present.  
 A negative membrane potential is considered a defining characteristic of 
astrocytes, as it is common to many astroglial sub-populations (Bordey & Sontheimer 
2000), and is considered critical for the astrocyte function of potassium buffering 
(Kuffler & Nicholls 1966, Orkand, Nichols & Kuffler 1966). All 1321N1 astrocytoma 
cell subtypes; P2Y1, P2Y2 and Parental cells, had highly negative reversal potentials. 
While this is not indicative of resting membrane potential it does imply a high relative 
conductance for potassium which is true for most astrocytes. P2Y1 and P2Y2 cell types 
had more negative reversal potentials than that of the Parental cell line. An increase in 
potassium conductance across a membrane will cause membrane hyperpolarization, and 
perhaps P2Y receptor expression facilitates increased potassium conductance under basal 
conditions. Both P2Y1 and P2Y2 receptor activity leads to increases in intracellular 
calcium (Burnstock 2007), which could activate BK channels. Exogenous ATP activation 
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of BK channels has already been observed in other cell types (Hafting & Sand 2000, 
Hafting et al. 2006).  
 Whole cell conductance of 1321N1 cells also was similar to that of cultured rat 
astrocytes (Li, Liu & Olson 2002). Again the P2Y1 and PY2 cell types demonstrate 
similar results that differ from those of the Parental cells. Parental cells generally 
displayed higher whole cell conductance than the P2Y1 and P2Y2 cells. 
Another defining electrophysiological characteristic of astroglial cells is the 
presence of outward-rectifying potassium currents that are inhibited by 4-AP and TEA 
(Bordey & Sontheimer 2000). Outward-rectifying currents were found consistently in the 
P2Y1 and P2Y2 cells and 10 mM TEA was able to inhibit the majority of this current at 
+80 mV. Parental cells did exhibit TEA-sensitive rectified currents, although not to the 
same extent as P2Y1 and P2Y2 cells. Again, BK channel activity in the 1321N1 cells 
could be tied to P2Y receptor function, and explain the lack of outward-rectifying current 
in the Parental cells. The concentration of TEA needed to inhibit 50% of the outward 
rectifying current was found to be 0.37 mM in P2Y1 cells, which is consistent with BK 
channel inhibition described in previous literature (Catacuzzeno, Pisconti, Harper, Petris 
& Franciolini 2000) as well as with other rectified K channels (Garcia-Diaz, Nagel & 
Essig 1983). 
 TEA was used in this study to block the basal rectified current and thus reveal 
other hyposmotically activated currents. While TEA effectively inhibits current measured 
at positive potentials it has little effect on the currents evoked at the more negative 
potentials near the reversal potential. The effect is that application of TEA did not have 
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significant effect on normalized conductance or reversal potentials in any cell line, and 
therefore it presumably did not inhibit any basal conductances.  
  
C. Electrophysiological Response to Hyposmotic Exposure (HOE) in 
PBS 
 
 The goal of the present study was to analyze the role of P2Y receptors in 
hyposmotically activated currents; specifically ICl,swell. While recording cells perfused 
with PBS, this was done in two ways. First, three subtypes of the 1321N1 human 
astrocytoma cell line was used. As explained in Methods, one subtype expressed P2Y1 
receptors, another P2Y1 and yet another lacked any P2Y receptor expression. By 
comparing cells transfected with either P2Y1 or P2Y2 receptors to the P2Y lacking 
phenotype, conclusions could be drawn as to their effect on hyposmotically activated 
currents. The second way was the use of PPADS, which is a broad spectrum nucleotide 
receptor blocker. PPADS is not specific for either of the subtypes used in this study, nor 
is it specific for P2Y receptors in general (Burnstock 2007). However, since it had no 
effect on Parental cells we can conclude that PPADS is specific for P2Y receptors in this 
study.  
 The response of P2Y1 and P2Y2 cells to HOE in PBS was significantly different 
than that of Parental cells. While all cell subtypes had increases in current amplitude and 
conductance, they differed in PPADS sensitivity and change in reversal potential. As 
stated above, Parental cells did not respond to PPADS. However, P2Y1 and P2Y2 cells 
showed significant inhibition of hyposmotic-induced current by PPADS. Also, the 
reversal potentials of P2Y1 and P2Y2 cells depolarize during HOE, while that of Parental 
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cells does not. In experiments where PPADS is present P2Y1 and P2Y2 cells respond to 
HOE by hyperpolarizing. This is similar to the response of Parental cells and thus, 
confirms P2Y receptor activity is responsible for the depolarization during HOE. 
 The depolarizing change in reversal potential seen in P2Y1 and P2Y2 cells during 
HOE could be interpreted as an increase in the conductance of chloride relative to that of 
potassium. In the PBS experiments EK = -93.4 mV and ECl = -2.8 mV, thus an increase in 
potassium conductance would result in hyperpolarization and an increase in chloride 
conductance would produce depolarization.  As discussed previously, a cell performing 
RVD would expel osmolytes and only potassium and chloride have electrochemical 
gradients directed out of the cell. If one was to assume that only potassium and chloride 
conductances change during HOE, then calculations of potassium and chloride relative 
conductance can be made using the Goldman-Hogkin-Katz equation. It would appear, 
based on reversal potential depolarization, that P2Y1 and P2Y2 cells experience an 
increase in the conductance of chloride relative to potassium during HOE from 0.0324 
and 0.0374 to 0.0907 and 0.1730, respectively. Similar calculations for Parental cells 
result in a decrease in the conductance of chloride relative to potassium during HOE from 
0.0829 to 0.0689.  
 
D. Electrophysiological Response to HOE in CsCl Solution 
 
 To better isolate ICl,swell in 1321N1 astrocytoma cells, equimolar concentrations of 
CsCl in the pipette and bath solutions was used. The ICl,swell-inhibiting drug DCPIB was 
also used in these CsCl experiments. Cesium was used in order to eliminate sodium and 
potassium conductance similar to other protocols (Decher et al. 2001, Abdullaev et al. 
80 
 
2006, Darby et al. 2003). Cesium is extremely impermeable to biological membranes and 
therefore chloride currents can be isolated (Diamond & Wright 1969). DCPIB was also 
used in these experiments as a selective ICl,swell inhibitor (Abdullaev et al. 2006, Decher et 
al. 2001). For reasons described in the results, morphologically distinct populations of 
cells were subjected to CsCl experiments. Recordings were made from morphologically 
flat 1321N1 cells of all three subtypes and from morphologically round cells of the P2Y1 
and Parental subtypes. 
Hyposmotically activated ICl,swell was identified in round P2Y1 and Parental cells, 
as well as flat P2Y1 and P2Y2 cells, but not in flat Parental cells. The hyposmotically 
activated current exhibited all characteristics that define ICl,swell. In all cases DCPIB was 
an effective inhibitor of the hyposmotically activated current and this DCPIB-sensitive 
current displayed slight outward-rectification in all cell types. Time inactivation at 
positive membrane potentials was present in all subtypes expressing the current. The 
inactivation was less pronounced than in the PBS studies, however the holding potential 
of 0 mV, instead of -70 mV, could have affected the channel kinetics. While prominent 
time inactivation for ICl,swell is seen at a holding potential of -80 mV (Shuba et al. 2004) it 
is much less pronounced when the holding potential is -50 mV (Decher et al. 2001) and -
40 mV (Chiang, Luk & Wang 2004).  
 Morphologically flat Parental cells do not exhibit ICl,swell, while round Parental 
cells do. The reason seems to be associated with the morphology of the Parental cells. 
The vast majority of 1321N1 cells of all subtypes are flat. Rounded cells appear much 
less often and appear to be either losing adhesion to the glass coverslip or are preparing to 
divide. One reason for ICl,swell not presenting in flat Parental cells could be differential 
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expression of membrane proteins during the cell cycle. A study in mouse liver cells also 
only identified ICl,swell in rounded cells (Wondergem et al. 2001). In this study round cells 
accounted for only 10% of the cell population, but were almost always found to be 
mitotic. Conversely, flat cells were consistently found to be not mitotic. ICl,swell may not 
be activated in flat Parental cells simply because it is not inserted into the membrane.  
 
E. Exogenous ATP Activates a Chloride Current 
 
 Experiments involving exogenous ATP in isosmotic medium were performed to 
determine whether P2Y receptors are sufficient to activate ICl,swell in 1321N1 cells. It is 
important to note that during these experiments round Parental cells were targeted, in 
order to be sure that channel expression was present. The concentration of ATP used in 
these experiments was 1 mM, which is well above the normal range for P2Y activation 
(Bours et al. 2006). Typical EC50s for P2Y1 are P2Y2 are around 21 µM and 1 M, 
respectively (May, Weigl, Karel & Hohenegger 2006, Meshki, Tuluc, Bredetean, Ding & 
Kunapuli 2003). A high concentration was used for two reasons. First, micromolar 
concentrations of ATP, similar to those that activate P2Y receptors, were not successful 
in activating any current. This could be attributed to ATP concentrations in the bulk 
media being different from those in the pericellular space (Joseph et al. 2003), due to 
multiple factors including ecto-ATPases that metabolize the ATP as it diffuses to the 
membrane. Second, even when 1 mM ATP was applied to the bath solution during 
Parental cell experiments there was no response. This indicates that the exogenous ATP 
is acting on the P2Y1 and P2Y2 receptors of the corresponding cells, and not some other 
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pathway. Current was also evoked in P2Y1 cells when a concentration of 500 µM ATP 
was used, although to a much lesser degree than when 1 mM ATP was used.  
 Without HOE, exogenous ATP still can activate a chloride conductance via P2Y 
receptor activation. Previous literature showed ADP is a more potent agonist than ATP 
for activation of chloride current in rat astrocytes, and suggests the P2Y1 receptor 
subtype as its mediator (Darby 2003). Currents are activated in both P2Y1 and P2Y2 
cells when exposed to exogenous ATP in CsCl solution, however the currents display 
characteristics dissimilar to that of ICl,swell. The ATP activated current lacks inactivation at 
depolarizing potentials and, more importantly, displays inward rectification. These 
characteristics were consistent in all P2Y1 and P2Y2 cells studied and indicate ATP 
activates a different current than ICl,swell. The ATP-induced current has a similar current-
voltage relationship to that of ClC-2 (Duann et al. 2000). Although ClC-2 has been 
shown to be dependent on intracellular ATP, no evidence exists for its activation by 
extracellular ATP (Roman et al. 2001). Another chloride current, aptly termed ICl,ATP 
responds to ATP, but does not demonstrate inward rectification (Yamamoto-Mizuma, 
Wang & Joseph 2004). 
 
F. P2Y Receptor Expression in P2Y1, P2Y2 and Parental Cell Subtypes 
 
 Great effort was made to identify P2Y receptor expression in the three 1321N1 
cell subtypes. Both western blotting and immunostaining were employed using 
polyclonal antibodies for P2Y1 and P2Y2 receptors. Commercially purchased antibodies 
were raised in rabbit from peptide antigens from the third intracellular loop, between 
transmembrane domains 5 and 6, of their respective receptors. Because antibodies for 
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P2Y1 and P2Y2 receptors were polyclonal and raised from similar domains there was a 
fear of cross-reactivity. To account for this, P2Y receptor antibodies were pre-incubated 
with the peptide antigen of the other P2Y receptor. This method was used in both western 
blotting and in immunostaining. 
Western and immunoblotting could not distinguish P2Y1 from P2Y2 receptor 
expression, however it did clearly show that Parental cells do not express either P2Y1 or 
P2Y2 receptors. In western blots, Parental cell lysates demonstrated bands for β-Actin but 
not for either P2Y1 or P2Y2 receptors. Parental cells were consistently negative when 
immunostained with either primary antibody. These results validate that the 
electrophysiological difference between the receptor and the Parental subtypes can be 
attributed to the P2Y receptor expression. 
 Western blots were positive for both receptor proteins in P2Y1 and P2Y2 cells. 
This was in spite of the fact that each antibody was pre-incubated with peptide antigen 
from the other receptor as described above. Immunostaining also revealed both P2Y1 and 
P2Y2 receptor expression in P2Y1 and P2Y2 cells. P2Y1 and P2Y2 cells that were not 
incubated with primary antibody demonstrated significantly less staining. Both of these 
facts indicate that the antibodies in question were staining for the intended receptors. 
However, pre-incubation of P2Y1 antibody with P2Y1 antigen and P2Y2 antibody with 
P2Y2 antigen during immunostaining did not significantly modify labeling of the 
receptors in both cell types. This implies that the control antigens were ineffective in 
absorbing the active antibodies and cross-reactivity could still be a problem. Further 
experimentation involving calcium mobilization in response to specific agonists should 
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be performed in order to clarify if P2Y1 and P2Y2 receptor expression is functional in 
the corresponding cell types.  
 
G. The Role of P2Y Nucleotide Receptors in ICl,swell Activation  
 
Previous literature has made the claim that exogenous ATP plays a role in ICl,swell 
activation via P2Y receptors, although the exact nature of this role has been debated. One 
set of studies argues that exogenous ATP is not necessary for ICl,swell activity, but 
potentiates the response when applied in addition to HOE (Mongin & Kimelberg 2003). 
These studies measured radiolabeled aspartate concentrations in perfusate from cells 
during HOE exposure in the presence and absence of ATP. Aspartate is known to be 
permeable to VRAC, the channel thought to be responsible for ICl,swell. Micromolar 
amounts of ATP were able to greatly increase aspartate release from cells during HOE, 
however exogenous ATP in the absence of HOE was unable to initiate aspartate release. 
Another study reported that exogenous ATP, released during cell swelling, is required for 
ICl,swell activation (Darby et al. 2003). These experiments employed voltage clamp 
techniques to record chloride current from cultured rat astrocytes in a fashion similar to 
the present study. The hyposmotically activated chloride current was inhibited by 
apyrase, as well as a number of nucleotide receptor blockers. Also, application of 
exogenous ATP in the millimolar range activated a chloride current. However, neither 
apyrase nor the P2Y receptor blockers were able to block the entire hyposmotic current. 
Neither study managed to directly answer the question of whether nucleotide signaling 
alone is sufficient to activate ICl,swell.  
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The goal of this study was to determine if P2Y signaling is necessary and 
sufficient for ICl,swell activation. When exposed to hyposmotic medium round Parental 
cells activate ICl,swell, demonstrating that P2Y receptor expression is not necessary. The 
lack of ICl,swell during HOE in flat Parental cells could demonstrate lack of expression of 
VRACs in the membrane, or that flat cells have a different cytoskeleton architecture that 
prevents significant swelling. It should also be pointed out that Parental cells in the PBS 
studies were also morphologically flat, which could explain why an increase in chloride 
conductance was not seen.  
 
H. Unanswered Questions and Future Directions 
 
As MacVicar and colleagues stated (in reply to Mongin & Kimelberg 2003), 
chloride channel activation is a complex phenomenon in astrocytes, and our findings are 
no different. Round Parental cells can clearly activate ICl,swell during HOE. Why are flat 
P2Y1 and P2Y2 cells able to activate ICl,swell during HOE and flat Parental cells are not? 
There may be multiple mechanisms for gating or membrane insertion of VRAC. Perhaps 
elevated intracellular calcium gates VRAC activation. P2Y receptor activation is able to 
gate VRAC by such a mechanism, as was seen in the flat P2Y1 and P2Y2 cells. Gating 
could also be accomplished by another mechanism related to the cell cycle (Wondergem 
et al. 2001). Whether the round Parental cells are in a different stage of the cell cycle than 
their flat counterparts is speculation at this point, however it would explain why round 
Parental cells are able to activate VRAC and flat Parental are not. Another question is 
whether exogenous ATP is activating ICl,swell or another population of chloride channels? 
The present voltage clamp experiments depicts the ATP activated current as having a 
86 
 
different electrophysiological profile than that of ICl,swell. This suggests that the current 
activated by 1 mM exogenous ATP is probably mediated by a channel other than VRAC. 
It has been shown that many chloride channels are activated during HOE (Zhang & Jacob 
1997). Considering ATP has been shown to reach P2Y activating concentrations in the 
pericellular space of astrocytes during HOE (Okada et al. 2006) it is not surprising that a 
portion of the chloride current evoked during HOE is sensitive to nucleotide blockers 
(Darby et al. 2003).  
Future studies are needed to determine how P2Y receptors are involved in gating 
ICl,swell and what channel mediates the ATP-activated current. Studies in CsCl using 
PPADS and other nucleotide receptor pathway antagonists could answer the question of 
how P2Y receptors affect gating or membrane insertion of ICl,swell. Electrophysiological 
and pharmacological characterization of the ATP-activated channel could lead to its 
identification. Finally, to reach beyond academic questions and into medical applications, 
in vivo research is needed to identify if ICl,swell plays a role in the physiological response 
to brain edema. If this role is better understood, then activity of ICl,swell could be modified 
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